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1. Introduction and objectives
1.1 Bone tissue engineering and scaffolds
As the rapid development of advanced medicine and technology, life expectancy of human
has increased greatly in the past decades. However, organ decay and decline caused by
aging, accidental injuries and serious diseases still threaten people’s health and decrease
the life quality. As bone as the instance, bone loss and osseous defects caused by aging,
trauma, tumor resection or infection remain severe health problems and challenges. Bone
graft, often applied in the clinical situation for treatment of lesions which cannot heal
spontaneously, has been recognized as an effective way to repair such defects and
regenerate bone function. However, autograft (although still being recognized as the “gold
standard”) or allograft, both have their inherent shortages, such as the limited availability
and donor site morbidity for autograft [1] or pathogen transmission and immune responses
for allograft [2,3]. Therefore, alternative strategies for bone repair and regeneration
involving tissue engineering (TE) approaches are required. TE is a fast developing field
since the definition was promoted by R. Langer and P. J. Vacanti in 1993 [4]. It aims to
generate living and functional tissues or organs in vitro by combining cells (such as
autologous stem cells isolated from the patient), synthetic scaffolds resembling the natural
extracellular matrix (ECM), growth-stimulating signals and bioreactor techniques [5-7].
According to this concept, biomaterials and 3D scaffolds made of them have to provide
mechanical support and an environment that facilitates cell attachment, migration, growth
and response to signals [8-10].
Bone tissue engineering (BTE) [11] is one of the fast-growing and exciting TE research
fields [12] since an increasing number of patients suffer from bone diseases, defects and
require bone repair and regeneration, which therefore also provided extensive market
demands and enormous economic benefits. Currently, great achievements have been
obtained from bench to bedside in BTE. From bench side, various novel biomaterials were
synthesised, modified and introduced in BTE. For example, carbon nanotubes (CNT) as
novel materials with unique mechanical, physical and chemical properties were introduced
as bone scaffolds [13]. Novel scaffolds have been prepared by using various techniques
such as electrospinning [14], rapid prototyping [15] and others. Such novel scaffolds not
only mimicked the structures (e.g. nano-fibers), but also copied the ECM functions (e.g.
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control the delivery of growth factors). On the other hand, numerous studies on stem cells
have gained wide and deep understanding on stem cell properties and behaviour, including
growth, induced differentiation and interaction with scaffolds [16]. In addition, various
modern and advanced techniques have been developed, including bioprinting living cells
[17,18] and cell co-culture techniques (e.g. bioreactors) [19,20]. Furthermore, increasing
work on BTE have been stepped into bedside including critical-size bone repair in large
animal models (e.g. sheep and horse) [21]. However, the ideal product from BTE for
clinical transplant is still not available, and numerous challenges still have to be solved.
As one of the indispensable factors in BTE, scaffolds should meet some requirements
concerning composition (biomaterials), structures (3D and porous) and functions [22]. The
biomaterials should be biocompatible, which means the materials must neither elicit an
unresolved inflammatory response nor demonstrate immunogenicity or cytotoxicity after
implantation in human body [23]. Biodegradability is another essential requirement for
biomaterials and scaffolds, and the degradation rate should be controlled to match with the
growth rate of new tissue [22]. In addition, the degradation products should also be
biocompatible and easy to be removed. The structure of the scaffolds should meet the
distinct external geometry pre-determined by the patient-specific defect, as well as realize
the defined pore structures for providing spaces and guiding cell migration, new bone
formation, as well as nutrient supply and vascularization [24]. The scaffolds for BTE not
only should meet the requirements of biomaterials and structures, but also should have the
required functions, such as the sufficient mechanical properties (mainly depended on
composition and structure) which were adapted with the surrounding tissues [25]. In
addition, the ability (function) of controlled delivery of drugs and growth factors (GF)
(such as bone morphogenetic proteins (BMP) and vascular endothelial growth factor
(VEGF)), which are able to stimulate new bone formation and vascularization are also
needed for bone scaffolds [26,27]. Furthermore, ideal scaffolds for BTE should have the
functions of supporting the attachment of osteoblasts and osteoprogenitor cells, providing
an interconnected pore structure which can permit bone growth on its surface or down into
pores, channels (osteoconduction), as well as stimulating undifferentiated and pluripotent
cells to develop into the bone-forming cell lineage (osteoinduction) [28].
Aim to fabricating the ideal scaffolds for BTE, much research have been performed,
including work on biomaterials (e.g. synthesis and modification of novel biomaterials),
structures (e.g. 3D porous structures fabrication techniques) and functions (e.g. sustained
GF delivery and vascularization) in the past decades.
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1.2 Biomaterials for scaffold fabrication
A broad range of biomaterials have been used for preparing scaffolds and implants for
bone tissue engineering, including metals, bioceramics and bioglasses, polymers and
composites thereof.
1.2.1 Metals
Metals such as titanium and titanium alloys have been used as bone implants for a long
time due to their excellent mechanical properties and biocompatibility [29,30]. However,
disadvantages of metals including lack of bioactivity (less desirable bone ingrowth) and
weak binding with bone (lack of direct biological fixation) forced numerous groups to
work on surface modification by coating a layer of calcium phosphates (CaP) with various
methods including sputter coating [31], electrophoretic deposition [32] and others.
However, another shortage of metals for BTE is that most metals are undegradable, which
makes them only applicable as bone implants and in that way the metals (especially
surface modified with CaP) was integrated within the host bone to stay and work
permanently. This is then not real tissue engineering scaffold because as the definition, the
scaffold should be degraded and finally be replaced by new bone. Therefore only some
degradable metals such as magnesium alloys might be suitable for preparing tissue
engineering scaffolds, but were also limited. Due to their fast corrosion and ion release
they were found to be extremely difficult to handle as matrix for cell cultivation in vitro
[33,34].
1.2.2 Bioceramics and bioglass
Bioceramics and bioglass are inorganic materials, which are used as bone filling materials
and bone scaffolds broadly due to their general bioactivity. CaP, as the most important
bone filling materials, have been extensively studied and used in BTE [35]. From the
biomimetic view, CaP would be the distinguished materials for BTE because they
resemble the inorganic composition of natural bone. The most important types of CaP
being using in BTE are hydroxyapatite (HAP) and β-tricalcium phosphate (β-TCP). 
Numerous studies and reports have proved that HAP and β-TCP are the excellent 
candidates for bone repair not only due to their biocompatibility and biodegradability, but
also because of their osteoconductivity and sometimes even osteoinductivity [36-38].
Compared to β-TCP, HAP is a more stable phase under physiological conditions, as it has 
a lower solubility and thus a slower resorption kinetics [39,40]. Beta-TCP, on the other
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side, degrades much faster than HAP, and therefore in composites of HAP and β-TCP 
named as biphasic CaP one is able to control the degradation rate by controlling the mass
ratio of HAP/β-TCP: the higher the ratio, the lower the degradation rate [41].
Except CaP, silicon based bioceramics and bioglasses are another type of increasingly
used and studied inorganic material for bone tissue engineering and regeneration. Silicon
is one of the important trace elements in human bone and is reported to stimulate new
bone growth [42,43]. For example, CaSiO3 scaffolds with high dissolution (degradation)
rates have strong new bone formation ability after implantation in vivo [44]. In addition,
various Ca-Si-P ceramics and glasses were developed and introduced into bone tissue
engineering, and one of the exciting example is the Ca-Si-P mesoporous porous bioglass
(MBG) [45,46]. MBG has a high specific surface area because of a high extent of regular
nano channels, and therefore has great potential for drug delivery.
Bioceramic scaffolds are biocompatible, biodegradable and have strong new bone
formation ability in vivo. However, brittleness is the main limitation for bioceramics and
bioglasses used as bone scaffolds.
1.2.3 Polymers and Biopolymer
Biodegradable polymers are another most widely used and studied materials in the BTE
field, including natural and synthetic polymers. Natural polymers (biopolymers) were
normally isolated from biological materials, and can be divided into several categories
according to their compositions such as polysaccharides (starch, alginate and chitosan),
proteins (collagen, gelatin and silk) and a variety of biofibers such as lignocellulosic fibers
[47]. The main advantage of biopolymers is their excellent biocompatibility [48].
Synthetic polymers, which used as BTE scaffolds include saturated aliphatic polyesters
(poly(lactic acid) (PLA), poly(glycolic acid) (PGA) and poly(ε-caprolactone) (PCL)), 
polyhydroxyalkanoates (e.g. polyhydroxybutyrate (PHB)) and others [49]. One of the
main advantages of synthetic polymers is their tailorable ability, to introduce various
properties by synthesis and modification, and process ability to manufacture 3D scaffolds
by different methods.
Alginate is a linear, anionic polysaccharide consisting of two kinds of 1,4-linked
hexuronic acid residues, namely β-D-mannuronopyranosyl (M) and α-L-guluronopyranosyl
(G) residues (Figure 1.1). It is a biocompatible and biodegradable material, which can
form a hydrogel in the presence of divalent cations (such as calcium) at mild pH and
temperature conditions. The divalent cations act as crosslinkers between the functional
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group of alginate chains (mainly the G residues) [50]. Due to these positive properties,
alginate has been widely utilized as drugs [51], growth factor [52] and even for cell
entrapment [53,54], and hydrogel/scaffold for tissue engineering [55,56]. For utilization as
growth factor and cell delivery carrier, alginate generally was prepared as microbeads by
injecting alginate sol into a solution containing divalent cations (such as CaCl2) through a
fine needle. However, 3D porous scaffolds of alginate required for tissue engineering were
prepared by several methods, including freeze-drying [57], diffusion ionotropic gelation
and deposition [58] and so on. On the other hand, alginate has a number of free hydroxyl
and carboxyl groups distributed along the backbone, therefore it can be chemically
functionalized by forming alginate derivatives. The properties such as solubility,
hydrophobicity and physicochemical and biological characteristics may be modified
through functionalization of hydroxyl and carboxyl groups [59]. For instance, RGD as
active peptide has been broadly introduced in alginate to improve cell attachment and
growth on alginate scaffolds [60,61].
Figure 1.1: Molecular structure of alginate ([62]).
In this thesis, alginate was selected as the main polymer for plotting scaffolds with or
without combination with other biomaterials not only due to its positive properties as
described, but also because of the excellent plotting ability.
1.2.4 Composites
Metals, bioceramics and polymers have their own advantages and disadvantages for
utilization in bone tissue engineering. Ideas of preparing composite by combining the
advantages of various materials were naturally developed, especially for preparing
composites of polymers and bioceramics by mimicking the ECM of natural bone. Bone
consists of carbonated HAP and collagen, which are precisely organized from the nano to
macro scal and form a hierarchical structure contributing to the excellent properties of
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bone such as the superior mechanical behavior. So far, numerous strategies and studies on
fabricating composite biomaterials and scaffolds have been proposed and performed. The
common idea was directly mixing bioceramics particles within polymer scaffold [63,64],
which is also the simplest method for preparing organic/inorganic composites. However,
due to the disordered structures and weak interaction between organic and inorganic
phases, the properties of such mixed composites have limited improvements. Another
extensive used method for preparing polymer/HAP composites was incubating polymer or
mixed polymer/bioceramics scaffolds in simulated body fluid (SBF) [65]. SBF is a
biomimetic solution with ion concentrations approximately equal to those of human blood
plasma [66]. After incubating a scaffold in SBF, a layer of apatite that is similar to bone
mineral can be deposited on the scaffold (mainly on the surface). This is a very useful
method to prepare polymer/apatite composites for BTE, because the formed apatite layer
not only enhanced the mechanical properties, but also improved the cell response and new
bone formation ability of these scaffolds. Several polymers including PLLA [67], PLGA
[68], PCL [69] and gelatin [70] have been studied and strong apatite layers were deposited
on such scaffolds after incubation in SBF or modified SBF (mSBF) (such as 5×, 10×SBF).
However, this method normally requires long time (several hours to several days) of
incubation, which might have a negative effect on the polymers (e.g. degradation) and
possibly embedded bioactive proteins (e.g. GF). In situ mineralization is an alternative
method for preparing polymer/apatite composite biomaterials and scaffolds [71, 72]. A
polymer solution is mixed with a calcium solution homogeneously, and then the mixture is
combined with a phosphate solution in a designed ratio (normally molar ratio of
Ca/P=1.67). Apatite is mineralizing on the polymer and forms a polymer/apatite
composite under suitable conditions (such as a suitable pH value). For example,
mineralized collagen fibers were fabricated through this process and the prepared
mineralised collagen tapes and scaffolds mimicking composition and structure of the ECM
of bone showed good cell response and are suitable for bone tissue engineering [73].
Anyway, although numerous methods and strategies have been used for building
polymer/ceramic (especially polymer/HAP) composite materials and scaffolds,
constructing an ideal polymer/HAP composite mimicking natural bone ECM remains a
challenge.
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1.3 Scaffold fabrication methods
Biomaterial composition determines the fundamental properties of scaffolds including
bulk and surface chemical, physical and biological properties. However, the3D structure is
another important factor influencing the properties of a scaffold as well as the cell
behavior. Especially the pore parameters such as the total porosity, pore size, distribution,
orientation and morphologies are essential [15,74-77]. Mechanical properties of scaffolds
decreased with increasing porosity. Studies on pore size, morphology and
interconnectivity have shown that they also have significant influence on cell behavior.
For BTE, some studies have revealed that scaffolds with pore size around 300 to 400 µm
were optimal [78,79]. However, some other studies demonstrated that scaffolds with a
pore size within 200-900 µm are well accepted for bone tissue engineering [80,81]. In
addition, a complete interconnectivity of the pores is also necessary for cell growth,
migration and homogeneous new bone formation in the scaffold. Pore size, morphology
and porosity are mainly depending on the scaffold preparation method. Until now, various
methods have been used to fabricate porous 3D scaffolds, including conventional methods
such as particle leaching, and novel methods such as electrospinning and rapid prototyping
(RP).
1.3.1 Conventional methods and electrospinning
According to the selected biomaterials, various methods have been developed to fabricate
porous 3D scaffolds for tissue engineering. One of the most widely used method is particle
leaching [82,83], which is suitable for preparing both polymer and some ceramic scaffolds
(e.g. CPC). Generally, the pore size can be designed by the porogen size, but the pore
interconnection usually is poor. An alternative way for preparing ceramic scaffolds is the
utilization of a porous polymer template (such as a polyurethane foam) which is coated
with ceramic slurry. By sintering that structure at high temperature, a stable, porous
ceramic scaffold is achieved while the polymer component is burned out [84]. This
method is only useful for preparing ceramic scaffolds. But because of the second sintering
step, drugs and biological factors can not be incorporate into the materials. Furthermore,
scaffolds prepared by this way were normally mechanical weak and brittle. For preparing
polymer scaffolds, other methods such as freeze-drying [85] and gas foaming [86] are
broadly used [87]. However, drawbacks concerning control of pore size and morphologies
still exist in these conventional methods.
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Electrospinning is an exciting novel technique for preparing nano/micro fiber mesh and
scaffold for tissue engineering [88,89]. Numerous works have been done by using this
technique to fabricate nano/micro fibers and various polymers have been used from
collagen [90], alginate [91] to PLGA [92], PCL [93] and others. Core/shell fibers also can
be achieved by co-electrospinning with a special core/shell nozzle [94]. However, it should
be mentioned that preparing 3D scaffold with defined macropores and sufficient
mechanical properties are still difficult to realize.
1.3.2 Rapid prototyping and 3D plotting
RP techniques have been introduced into the tissue engineering field for fabricating 3D
porous scaffolds in the past decades. The principle of RP, also known as solid free form
fabrication, is the generation of scaffolds through layer-by-layer construction of 3D
structures with predefined inner and outer geometry. Basis for the computer-assisted
design (CAD)/ computer-assisted manufacture (CAM) data sets can be computer
tomography or magnetic resonance tomography of the defect region, which are used to
generate a virtual 3D model that is then converted into a sequence of slices which are used
to build the corresponding real 3D object in layer-by-layer fashion [95,96]. In contrast to
conventional methods used for scaffold fabrication, the preparation of molds as well as
subsequent machining steps for shaping are not necessary. Thus, the main advantage of
RP techniques is the possibility to design and control the architecture of a scaffold – not
only with respect to the external geometry pre-determined by size and shape of the
patient-specific defect since also a defined pore structure including channels for nutrient
supply and vascularization can be realized.
A number of RP techniques has been successfully adapted for processing of biomaterials
into 3D scaffolds such as systems based on laser technology (stereolithography and
selective laser sintering), devices using printing technology (3D printing) and extrusion-
based systems [95,96]. 3D plotting as well as fused deposition modeling, which belong to
the last group, function by dispensing strands of a pasty or molten material through a
moving nozzle to build a 3D structure in layered fashion [96]. However, whereas fused
deposition modeling is restricted to thermoplastic materials with good melt viscosity, a
wide variety of synthetic and natural materials can be processed by using the technique of
3D plotting.
Examples for materials which can be used for scaffold preparation applying the 3D
plotting technique, originally developed by Mühlhaupt and co-workers at the Freiburg
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Materials Research Center (Germany), are hydrogels [97-99], HAP ceramic slurries [100],
polycaprolactone [101,102] and starch-based blends [103]. In contrast to other 3D
extrusion technologies, the mild process conditions (room or physiological temperature
and no usage of organic solvents) allow simultaneous plotting of biological components
such as antibiotics, growth factors and even living cells which are suspended in the
respective plotting material [104].
There are three strategies to engineer tissues, tissue substitutes or even organs by using RP
technologies (Figure 1.2). According to the first, the scaffold is fabricated by processing
an adequate biomaterial into 3D porous scaffolds with predesigned outer and inner
structure. In principle, each RP method described above can be used if it is suitable for the
respective material. After fabrication, the scaffold can be modified to improve its
properties. Subsequently, living cells (e.g. stem cells) are seeded and cultured on the
sterilized scaffolds in vitro and the construct finally is implanted in vivo. The main
advantage of this strategy is the nearly unlimited feasibility to modify the scaffolds,
because living cells were introduced after scaffold fabrication is completed. For example,
biomaterials and scaffolds can be modified by introducing active groups or improving
mechanical properties under chemical reaction and heat treatment during processing
and/or post-processing. However, the disadvantage of this strategy is that cell seeding is
relatively uncontrolled and often associated with a low seeding efficiency and
inhomogeneous cell distribution. Although a number of upgraded cell seeding techniques
has been developed resulting in an improvement of cell seeding efficiency and
distribution, such as semi-dynamic or dynamic cell seeding techniques, using rotating or
shaking systems, spinner flasks or bioreactors, this strategy has limitations with respect to
seeding of more than one cell type or seeding with defined location/distribution of the
cells.
One of the most exciting features of the RP technique 3D plotting is the possibility to
integrate delicate biological compounds and even cells into a scaffold during the
fabrication process. Therefore, this technique is suitable to realize the second strategy,
which comprises the simultaneous processing of living cells and biomaterials into cell-
matrix-constructs. This is realized by mixing cells, optionally growth factors or other
supporting factors and the pasty biomaterial prior to scaffold fabrication followed by
plotting of these multi-component paste under sterile conditions. Prerequisite for this
strategy is the possibility to stabilize the biomaterial after plotting in a cell-compatible
way which is the most limiting factor. In addition, the plotting material meeting the
stringent requirements with respect to cell
stif
incubated in cell culture medium
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the use of inkjet printing [106,107] and mechanical extruders by using ‘bio-ink’ particles
[108]. The typical example is plotting multi types of cells for vascularization. Endothelial
cells, smooth muscle cells and fibroblasts were plotted layer by layer to mimic the
vascular structures on the cell level. However, there are still some challenges, such as to
achieve appropriate structural organization and functionality [109].
1.4 Drug & growth factor (GF) delivery from scaffolds
Drug delivery is another important research field apart from tissue engineering. Numerous
studies have been done in this field and various excellent strategies have been promoted
including sustained drug delivery, targeted drug delivery and triggered drug delivery. To
achieve these advanced strategies, the design of drug carriers is the key factor. Most of the
drug carriers were produced as nano/microspheres or particles [110,111] because they
offer the advantage of avoiding surgical procedures and can be administered orally or
injection. Especially, nanospheres are able to participate in intracellular trafficking [112].
From the pharmaceutical perspective, nanospheres are the ideal drug vectors. With a
certain surface modification, drug loaded nanospheres can selectively be attached to target
cells and release drugs by specific triggers (e.g. pH value) to kill for example cancer [113].
However, standing from tissue engineering point, 3D scaffold as the main carriers for cells
should be further considered as the vector for drugs and growth factors [114,115]. The
scaffold itself, of course, can be a direct or indirect vector for drug and GF. Direct vector
means drugs or GF are loaded directly in the scaffold by physical interaction or chemical
reaction. Indirect vector means drugs or GF are loaded in other vectors such as
nano/microspheres at first, which then are introduced into scaffold [116].
In the case of scaffolds as direct vector, the methods for loading drugs and GF into
scaffolds include mixing drugs with biomaterials prior to scaffold fabrication and
introducing drugs into already fabricated scaffolds. Compared to the method of drug-
loading into fabricated scaffolds, method of direct mixing drugs with biomaterials has the
advantage of a homogeneous distribution of drugs in the scaffold, but the disadvantage of
being only applicable for mild scaffold fabrication conditions. In case of loading drugs
into fabricated scaffolds mild scaffold fabrication conditions are not required, but this
method has a low loading efficiency. These two drug loading methods are very simple, but
drug and GF release from these scaffolds is very fast and normally fail for long term
delivery [117]. Therefore, various modification methods were promoted, such as chemical
binding of drugs or GF onto the scaffolds instead of direct mixing. For example, VEGF
was introduced in CPC modified with heparin and data showed a sustained release
behavior [118].
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In the indirect vector delivery system, first drugs and GF are loaded in nano/microspheres
or particles. Afterwards, the drug loaded nano/microspheres or particles were embedded or
grafted into scaffolds. Drug release behavior can mainly be controlled by the
nano/microspheres, as well as by the scaffolds. Except the control of the release behavior,
drug and GF loading into the carries is also an important issue, especially for GF because
their biological activities are very sensitive to the environmental conditions, such as
temperature, pH value and ions concentrations etc. The most innovative technique for
entrapping osteoinductive factors into polymeric microcapsules may be the double-
emulsion-solvent-extraction method [119-121], because this method can successfully
maintain the biological activity of the GF.
Conventional delivery systems with a single drug or GF release either directly from the
scaffold or from incorporated nano/microspheres have been developed and studied widely.
However, only one type of GF might be insufficient for bone regeneration or other types
of tissue engineering. Dual or multi systems are required to release more than one growth
factor encapsulated either in nano/microparticles or matrices/scaffolds in a
spatiotemporally controlled manner [27]. Figure 1.3 illustrates the dual delivery system,
in which the scaffold works as both direct and indirect carriers. One type of GF is loaded
in the nano/micro-particles which are then introduced in the scaffold and another GF is
directly loaded into the scaffold. Furthermore, more than two types of GF can be delivered
by this system by loading different types of GF in different nano/micro-particles.
Figure 1.3: The schematic illustration of conventional versus dual release system ([27]).
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1.5 Scaffolds for vascularization
Tissue engineering has gained great achievements and some of the engineered tissues have
been used in clinics successfully like skin and cartilage [122-124]. However, the success
in tissue engineering is limited to those thin or non-vascularized tissues, for large tissues
and organs, it remains a big challenge. For those tissues beyond 200 µm (the diffusion
limit of oxygen), new blood-vessel formation is required. Otherwise, after implantation of
the tissue constructs, the supply of oxygen and nutrients to the implant is limited and leads
to the clinical failure. Many studies concerning vascularization in vitro and in vivo have
been performed and various strategies were promoted [125-128]. Three important factors
are commonly considered: cells (endothelial cell (EC) and stem cell), growth factors
(VEGF) and scaffolds (porous scaffold or hydrogels) [125].
Porous scaffolds with the function of sustained release of angiogenic factors including
VEGF, basic ﬁbroblast growth factor (bFGF) and the hepatocyte growth factor (HGF) is 
the considered candidate for promoting vascularization [129]. However, some challenges
including the instability of angiogenic factors in vivo, and the related techniques involved
in the GF delivery from scaffolds must be solved. Another scaffold-based strategy for in
vitro prevascularization is fabricating tube-like constructs and seeding with EC and
optionally with other cell types such as myoblasts or ﬁbroblasts. The construct is cultured 
in vitro with the objective of building 3D prevascularized structures. Subsequently, the
construct with the rudimentary vascular network is implanted into the ischemic area [125].
One of the main requirements for this strategy is the formation of blood-like structures.
Various techniques have been applied to fabricate such tube-like structures and for their
integration into 3D scaffolds [130]. Challenges including seeding of multi-types of cells
with defined location and the cells co-cultivation of different all types should be
considered further.
1.6 Objectives and aims
The objective of the thesis was to develop scientific and engineering knowledge for
fabricating novel scaffolds for bone tissue engineering and regeneration based on polymer
and ceramic biomaterials by the using multi-channel 3D plotting technique. The fabricated
scaffolds with pre-defined structures, as well as multiple functions such as drug/protein
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delivery and vascularization were studied in vitro. The specific objectives of this thesis
were:
 Fabricating calcium phosphate scaffolds by plotting a novel ready-to-use CPC
paste under mild conditions, and optimising the plotting parameters and evaluating
the scaffolds in vitro.
 Manufacturing stable alginate scaffolds by plotting newly developed concentrated
alginate pastes, and studying the effect of adding polyvinyl alcohol (PVA).
 Designing and preparing CPC/alginate biphasic scaffolds and bi-layered scaffolds
for repairing osteochondral defects by plotting the ready-to-use CPC paste and
concentrated alginate paste simultaneously.
 Preparing an alginate/apatite core/shell scaffold by 3D plotting technique and in
situ mineralization. The core/shell scaffold was evaluated in vitro by testing the
mechanical properties, cells response and protein delivery.
 Synthesis of mesoporous bioactive glass (MBG) and introducing it into
hierarchical scaffolds either by direct plotting MBG/PVA pastes in which MBG is
the main part and PVA the binder to bind the MBG particles, or adding MBG
powder (as additive) to alginate scaffolds. The scaffolds were investigated in vitro
including mechanical properties, cell growth and differentiation. Finally drug
loading in the MBG part and delivery from the scaffolds were explored.
 Trying to widen the plotting materials by plotting gelatin/alginate and
gelatin/alginate/ HAP scaffolds, and their potential for bone tissue engineering
application was studied including mechanical properties and cell response.
 Developing novel hollow fiber scaffolds made of alginate utilising novel core/shell
double needles and the 3D plotting system under mild conditions. The developed
hollow fiber scaffolds should be introduced as template for guiding vascularization
in vitro.
Through plotting various scaffolds with predesigned structures and functions based on
polymers and ceramics, this thesis trying to demonstrate that:
1. Considerable pasty materials including organic and inorganic substances can be
utilized by 3D plotting through suitable preparing methods.
2. Scaffolds consisting of different materials can be fabricated by the 3D plotting
technique for achieving various functions such as enhanced mechanical properties,
drug delivery and vascularization.
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3. 3D plotting can provide great achievements in the field of tissue engineering by
preparing advanced scaffolds, as well as by plotting cell/matrix constructs, and
even complex tissues and organs.
4. Those scaffolds would be potentially useful for bone tissue engineering, and
furthermore the described scaffolds and techniques might be also interesting for
other application such as cartilage and soft tissue engineering.
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2. Calcium phosphate (CaP) and CaP/alginate scaffolds
2.1 Introduction
Calcium phosphate (CaP) based materials are the distinguished candidates for bone repair
and regeneration because of their excellent properties such as osteoconductivity and due to
the fact that calcium phosphates are the most important inorganic constituents of
biological hard tissues. They have been prepared as injectable cements for clinical use and
3D porous scaffolds for bone tissue engineering. As mentioned previously, the overused
method for preparing porous CaP scaffolds was particle leaching. In this method, either
water soluble particles (such as NaCl2 crystals) or those dissolvable in hydrophobic
organic solvents (like paraffin) are incorporated as porogens into CaP pastes. After
shaping, the CaP scaffolds are incubated in water for setting and dissolving the porogens
that leads to mechanically loadable porous structures – or are treated with an organic
solvent after setting [131]. An alternative way is the utilization of a porous polymer
template (such as polyurethane foams) which is coated with a CaP slurry. By sintering that
structure at high temperatures, a stable, porous CaP scaffold is achieved while the polymer
component is burned out [84]. However, these methods are limited by poor control of pore
size and morphology as well as insufficient pore interconnectivity.
In addition, lot of work has been invested in the fabrication of CaP scaffolds by 3D
printing, also referred to as powder printing. In this process, calcium phosphate particles
are bonded using a liquid binder which is delivered by an inkjet printing head [132]. After
the printing process, the binder-free powder is removed and the remaining structure is
stabilized – in most cases by sintering that result in a ceramic body possessing high
crystallinity and mechanical stability [133, 134]. Using this technique, scaffolds with
designed pore parameters were fabricated successfully. However, there were still some
shortages such as the difficulty to remove unbound powder.
As an alternative strategy, 3D extrusion approaches of CaP pastes and slurries,
respectively, were developed. Miranda and co-workers used so-called ceramic inks, highly
concentrated, water-based suspensions of -tricalcium phosphate or HA powder, which
are dispensed through a moving deposition nozzle in an oil bath to build a ceramic
scaffold [135-138]. This process, introduced in the literature as “robocasting” or “direct
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write assembly”, is very similar to the technique of 3D plotting. After building, the
scaffolds were dried and sintered at high temperature resulting in ceramic bodies.
However, the second sintering hinders loading of drugs, growth factors and living cells in
the CaP pastes. Therefore, in this work, plotting and post-processing steps are conducted
without any heat treatment or involvement of organic solvents that allows – in contrast to
other RP techniques used for production of calcium phosphate scaffolds such as powder
printing or selective laser sintering – the incorporation of delicate pharmaceutical and/or
biological components like antibiotics, drugs, growth factors or even autologous
constituents such as blood components or living cells during scaffold fabrication.
On the other hand, conventional powder/liquid CPC pastes are prepared by mixing solid
calcium phosphate cement precursors with water or an aqueous Na2HPO4 solution
resulting in an injectable paste that sets and hardens within a few minutes. This type of
CPC paste is suitable and frequently utilized for filling of bone defects in clinical
applications, however, the fast setting reaction and hardening behavior prevents its usage
for scaffold fabrication by 3D plotting since the powder/liquid CPC would block the
nozzle with time. This limitation is circumvented by the application of a newly developed
CPC paste (P-CPC; patent applied by InnoTERE, Dresden, Germany) which can be stored
as malleable paste for months [139]. Therefore, in this thesis, scaffolds were fabricated by
plotting this newly developed CPC and their mechanical properties and cytocompatibility
were studied in vitro.
Furthermore, an organic/inorganic biphasic scaffold with improved mechanical properties
was developed by plotting CPC and concentrated alginate pastes simultaneously. In
addition, another novel alginate/apatite core/shell scaffold based on the concentrated
alginate pastes and the method of 3D plotting and in situ mineralization was also
fabricated. The novel scaffolds were characterized by SEM, FTIR, XRD and mico-CT.
The properties of the core/shell scaffold were studied in detail including mechanical
properties, cell culture and protein delivery.
2.2 Materials and methods
2.2.1 Introduction of the multi-channel 3D bioplotter system
A 3D bioplotting system, developed by the Fraunhofer IWS (Dresden) based on the Nano-
PlotterTM from GeSiM (Großerkmannsdorf, Germany), was applied in this work (Figure
2.1 A)
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plotting speed. After each strand was plotted, the given air pressure was terminated and a high
tear off speed was given to disrupt the strand at the end, and then the plotter unit lifted and
moved to the start point of the next strand. After one layer was finished, the plotting unit moved
up a certain height in z direction and started the next layer as described. The moved height was
also pre-set according to the plotting needle size. The process was repeated until the whole
scaffold was finished. Size and shape of the resulting structure is predefined by the CAD data set
but depend also on the dosing pressure, the plotting speed and the diameter of the dosing nozzle
[24].
2.2.2 Preparing ready-to-use CPC pastes
The powder component of the pasty calcium phosphate cement (P-CPC; patent applied for
by InnoTERE, Dresden, Germany) is described in Khairoun et al. [140]. In short, the
cement powder consisted of 60% α-tricalcium phosphate, prepared by solid-state sintering 
of calcium carbonate and calcium hydrogen phosphate at a calcium:phosphate ratio of
1.45 at 1300°C in air, 26% dicalcium phosphate anhydride, 10% calcium carbonate and
4% precipitated HA. All constituents are premixed and subsequently ground in 500 ml
agate jars in a planetary ball mill with 30 mm agate balls (Fritsch, Germany) at 200/min
for 3×15 min at 10 min intervals. The carrier liquid of the cement paste is prepared from a
short-chain triglyceride (short-chain fatty acid esters of glycerol with 8–12 C atoms;
Miglyol 812, Cäsar and Lorentz, Germany), Polysorbate 80 (Tween 80, Merck, Germany)
and phosphoric acid monohexadecyl ester (Amphisol A, DSM Nutritional Products,
Switzerland) at a mixing ratio of 15:3:2, respectively, under heating and stirring until a
clear solution is obtained. The P-CPC is typically prepared by mixing 80 g cement powder
with 20 g carrier liquid in a porcelain mortar with a pestle until a homogeneous paste is
obtained. The paste is subsequently ground in 500 ml zirconium dioxide jars with 30 mm
balls for 4 h at 300/min in a planetary ball mill (Fritsch) [139]. The resultant paste is then
transferred into 5 ml cartridges and stored in a desiccator until further use. Variations in
paste consistency were prepared by varying the powder: carrier liquid ratio [24].
2.2.3 Plotting 3D CPC scaffolds
The prepared CPC paste was loaded in a plotting cartridge which was equipped with
dosing needle and air pressure connection, and then was inserted in the plotting channel.
The 3D CPC scaffolds were then fabricated by extruding the materials through the dosing
needle layer by layer as described in 2.2.1. The CAD models were designed with different
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pore sizes (from 200 µm to 1.5 mm) and strands orientation (square, triangle of 60° and
45-90-45°). The effect of plotting speed and dosing air pressure on plotted strands were
studied by using different needles with inner diameter from 200 µm to 840 µm.
An option to enhance the size of pores in Z direction (oriented parallel to the X- and Y-
axis) was explored by fabrication of CPC scaffolds using a supporting paste which fills
temporarily the space between the CPC strands. The supporting paste could be removed
easily after plotting and stabilization of the CPC scaffolds in water. For this purpose, a
paste consisting of polyvinyl alcohol (PVA), a water-soluble synthetic polymer, was
selected and prepared as follows: firstly, a 15 wt.-% PVA solution was prepared by
dissolving PVA powder (Sigma-Aldrich, Taufkirchen, Germany; average molecular
weight: 130,000) in deionized water (preheated to 90°C) under magnetic stirring. After
complete dissolution of the PVA powder, the solution was continuously heated to
evaporate some of the water and stirred by hand during this time until a highly viscous
paste of 25 wt % PVA was achieved. The PVA paste was cooled down to room
temperature and filled into a plotting cartridge. For the plotting process, two cartridges
were used: one was filled with CPC and the other-one with PVA paste. After deposition of
the CPC strands for the first layer, the PVA paste was deposited into the gaps between two
CPC strands for supporting the next layer. This process was repeated for each layer
minimising the compression of the plotted structure until the whole scaffold was finished.
The diameters of dosing needles were 840 µm for CPC and 410 µm for PVA paste,
respectively. The plotting speed was kept at 5 mm/s and the dosing pressures were ranged
from 0.95 bar to 1.5 bar for both CPC and PVA paste [24].
After the scaffolds were fabricated, they were transferred into deionized water to start the
setting reaction of CPC and removal of the included biocompatible oil and also for
dissolving the sacrificial PVA paste. They were stored in water for 1 week, with a change
of water twice daily. Finally, the scaffolds were dried at room temperature for further use.
2.2.4 Preparing alginate/PVA pastes and scaffolds
The concentrated alginate pastes were prepared by mixing sodium alginate powder
(Manugel®; ISP Alginates Ltd. Waterfield, Tadworth, U.K.) with PVA solution. First of
all, PVA aqueous solutions with concentration of 6% w/v, 7.7% w/v and 12.5% w/v were
prepared by dissolving PVA in hot deionized water (preheat at 90°C) under magnetic
stirring. After PVA particles dissolved completely, heating was terminated and the
solution cooled down to room temperature. Then certain mass ratios of alginate powder
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and PVA solution were mixed and stirred vigorously by hand until homogeneous pastes
were achieved, which then were loaded into cartridges for plotting. Three different
concentrations of alginate/PVA pastes were studied including those with the mass ratio of
alginate/PVA being 1:1, 2:1 and 3:1, which were prepared by mixing alginate to 12.5%,
7.7% and 6% PVA solution in a mass ratio of 1:8, 1:6.5 and 1:5.5, respectively. Pure
alginate paste, as control, was prepared by mixing alginate with deionized water in mass
ratio of 1 to 5.5.
The scaffolds were plotted as described in section 2.2.1 in detail. Cone-like plastic needles
with an inner diameter of 610 µm were used. The plotting speed was set to 4 mm/s and the
dosing pressures were adjusted according to the alginate/PVA mass ratio (see Table 2.1).
After scaffolds fabrication, they were transferred to 500 mM CaCl2 solution for
crosslinking of alginate and simultaneously dissolving of PVA for about 5 h. Then the
scaffolds were washed with deionized water three times and dried at room temperature for
further use.
2.2.5 Preparing biphasic alginate/CPC scaffolds
CPC paste and alginate/PVA paste (ratio of alginate/6% w/v to PVA solution = 1/5) were
prepared as described in above sections 2.2.2 and 2.2.3. CPC paste and alginate paste were
filled into two different plotting cartridges and plotted alternately through needles with an
inner diameter of 610 µm. The plotting speed was kept at 3 mm/s and dosing pressures
were 7.4 bar for alginate/PVA paste (plastic needle) and 5.0 bar for CPC paste (stainless
steel needle). As control, mixed alginate/PVA, CPC and CPC/alginate/PVA scaffolds
were also fabricated. For preparing mixed CPC/alginate/PVA scaffolds, alginate powder
and CPC precursor powder (mass ratio of alginate/CPC was 1) were mixed firstly, and
then 6% w/v PVA solution was added to the mixed powders (mass ratio of mixed
powder/PVA solution was 1/4.5) and then stirred into a homogeneous paste by hand.
Alginate, CPC and mixed CPC/alginate/PVA pastes were filled in a plotting syringe and
plotted with constant speed of 3 mm/s and dosing pressure of 7.4, 5.0 and 8.5 bar via
nozzles with an inner diameter of 610 µm, respectively. All scaffolds were plotted with
XXYY pattern, which means the pastes were deposited in the x direction as two layers
(the second layer was on top of the first layer), and in the y direction as the next two
layers, then repeated until the whole scaffold was finished. After that, alginate, biphasic
CPC/alginate and mixed scaffolds were transferred into 1 M CaCl2 solution for
crosslinking alginate for 5 h. Afterwards, pure alginate and mixed CPC/alginate scaffolds
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were washed three times with deionised water and dried at room temperature. CPC and
biphasic CPC/alginate scaffolds were transferred to deionised water for continuation of the
removal of the biocompatible oils for 1 week. Water was changed twice per day, then the
scaffolds were dried at room temperature.
In addition, biphasic scaffolds for repair of osteochondral defects based on CPC/alginate
were also fabricated. After biphasic CPC/alginate scaffolds were fabricated as described
above for bone repairing part, the alginate/PVA paste was continuously plotted on top of
the CPC/alginate scaffold for cartilage repair part. The structure and size can be designed
by CAD. After the whole scaffold was finished, it was transferred to a 1 M CaCl2 solution
for crosslinking of alginate and setting of CPC.
2.2.6 Preparing alginate/apatite core/shell scaffolds
The plotting alginate/apatite pastes were prepared by mixing alginate powder with a
freshly prepared aqueous 500 mM Na2HPO4 (Sigma-Aldrich Germany) solution in mass
ratio of 1 to 5.5. The pastes were stirred into homogeneously by hand and then filled into a
plotting cartridge. 3D scaffolds were fabricated by extruding the pastes through cone-like
plastic needles (ID = 610 µm) using the 3D plotting system, described in detail in section
2.2.1. The plotting speed was 4 mm/s and the dosing pressure 4.0-4.5 bar. Afterwards, the
scaffolds were transferred to a 1 M CaCl2 solution, of which the pH value was adjusted to
9.5 by Tris buffer and the unadjusted pH value (pH5) was used as control. After soaking
in CaCl2 solution for 3 h, the scaffolds were washed with deionized water three times and
then dried at room temperature. As control, pure alginate and mixed alginate/
hydroxyapatite scaffolds were fabricated by mixing alginate and alginate/hydroxyapatite
(mass ratio of alginate/HAP was 3 to 1) with deionized water instead of Na2HPO4
solution.
2.2.7 Characterization of scaffolds
2.2.7.1 Optical microscopy and SEM analysis
The diameter of CPC strands, pore size and structures of all prepared scaffolds were
characterized by optical microscopy (Stemi 2000-C, Zeiss, Germany) and scanning
electron microscopy (SEM). For SEM analysis, the samples were coated with carbon and
imaged using a Philips XL 30/ESEM with FEG (field emission gun), operating in SEM
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mode. For analysis of cross sections, the samples were cut with a blade and coated with
carbon.
2.2.7.2 Porosity, water adsorption and weight loss
The porosity was measured by the liquid displacement method according to the literature
[141]. In brief, a scaffold was immersed in a graduated cylinder with a record volume of
99.9% ethanol (V1). Then the cylinder was placed in reduced pressure that forced the
ethanol into the pores of the scaffold until no bubbles appeared and the resulting volume
of ethanol was marked as V2. The scaffold was removed and the volume of the remained
ethanol was recorded as V3. The porosity (p) was calculated by the following equation:
(2.1)
Shrinkage of the scaffolds was calculated by measuring the length and height of the
scaffolds before and after drying.
The water adsorption and weight loss of alginate/PVA scaffolds were studied. Dry
samples were incubated in phosphate buffered saline (PBS) solution (pH 7.4) at 37°Ϲ. At 
certain time points (0.5, 1.5, 3 and 5 h), three samples of each type were taken out and put
on a filter paper to remove the water on the surface and then weighed. The water
adsorption was calculated according to the following function:
(2.2)
In which W1 and W2 represent the weight of wet scaffold after soaking in PBS and weight
of dry scaffold before soaking in SBF, respectively.
For studying weight loss of alginate/PVA scaffolds, dry samples were incubated at
simulated body fluid (SBF) with ion concentrations similar to those in human blood
plasma was prepared according to the method described by Kokubo [142] at 37°C. At
each time point (1, 7, 14, 21, 28, 35 and 42 d), three samples of each type were taken out
and washed with deionized water three times. After drying until scaffolds with constant
weight were achieved, the weight loss was calculated using the following function:
(2.3)
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In which, Wb and Wa represent the dry weight of scaffolds before and after incubation in
SBF.
2.2.7.3 XRD, FTIR, and EDS analysis
The plotted CPC scaffolds before and after setting in water were characterized by X-ray
diffraction (XRD) (Bruker D8 with area detector Vantec 2000). The measurement was
performed with Cu-Kα radiation, angle range was 9°<2Θ<62°, and each diffractogram 
was made of two frames, each frame of 10 min.
The plotted alginate/apatite core/shell scaffolds were characterized by XRD, Fourier
transform infrared spectroscopy (FTIR) (Spectrum 2000, Perkin Elmer, USA), SEM and
Energy dispersive spectrometry (EDS). XRD measurement was performed with Cu-Kα 
radiation, angle range was 18°<2Θ<70° and each diffractogram was made of two frames, 
each frame of 12 min. Samples for FTIR analysis were prepared by grinding scaffold
particles with KBr, followed by pressuring of a tablet.
2.2.8 Mechanical tests
For all types of plotted scaffolds compression test were performed by an Instron 5566
testing machine (Instron Wolpert GmbH, Darmstadt, Germany) were equipped with a 10
kN load cell. Force was given on the Z-direction of scaffolds with a constant compression
rate of 1 mm/min. Young’s modulus was calculated according to the obtained stress-strain
data and curves. The mechanical properties were tested on dry and wet scaffolds at room
temperature (25°Ϲ), respectively. Wet scaffolds were prepared by incubating dry scaffolds 
in SBF at 37°Ϲ for 2 h. Five samples of each scaffold type were tested for mean and 
standard deviation calculation.
2.2.9 Cell culture
The cell culture experiments performed on the plotted scaffolds were all carried out
following the same protocol, which is described in detail as follows. All the scaffolds were
sterilized by gamma-radiation at 25 kGy before seeding cells.
2.2.9.1 hBMSC culture and seeding on scaffolds
Human bone marrow derived mesenchymal stem cells (hBMSC), kindly provided by the
Medical Clinic I, Dresden University Hospital “Carl Gustav Carus” (Prof. Bornhäuser and
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co-workers), were cultivated in Dulbecco’s Modified Eagle’s Medium low glucose
(DMEM) (Biochrom, Berlin, Germany) containing 10% fetal calf serum (Biochrom), 10
U/ml penicillin and 100 µg/ml streptomycin (Biochrom) at 37°C and 8% CO2. Cells in
passage 4-6 were used for seeding of the scaffolds.
For the plotted CPC scaffolds, a semi-dynamical cell seeding technique was applied. In
detail, after the CPC scaffolds were pre-incubated in cell culture medium for 24 h, they
were placed into tissue culture flat tubes with a growth area of 10 cm2 (TPP, Trasadingen,
Switzerland) for cell seeding (3 scaffolds per tube). 1 × 106 cells were used for seeding of
one scaffold, therefore, 3.5 ml cell culture medium containing 3 × 106 cells were given
into each tube for seeding of 3 scaffolds. The tubes were placed overnight in an incubator
(37°C and 8% CO2) and gently shaken for semidynamic seeding. Thereafter, cell-seeded
scaffolds were placed in tissue culture plates and cultivated with osteogenic supplements
(10-7 M dexamethasone, 3.5 mM β-glycerophosphate and 0.05 mM ascorbic acid 2-
phosphate; all purchased from Sigma-Aldrich) for 19 days [24].
For the plotted biphasic CPC/alginate scaffolds and alginate/apatite core/shell scaffolds,
the conventional cell seeding method was used. In detail, after the scaffolds (5×5×3.5 mm)
were pre-incubated in cell culture medium for 24 h, they were placed on sterile filter paper
to remove excess liquid from the pores. Samples were placed in 48-well polystyrene
culture dishes and cell suspension was given onto the top of each scaffold. After
cultivation for 24 h, the cell-seeded scaffolds were transferred to fresh culture dishes. 5 ×
105 and 5.5 × 105 cells (passage 5) within 400 µl of medium were given to biphasic
CPC/alginate and alginate/apatite core/shell scaffolds, respectively. Medium was changed
twice per week.
2.2.9.2 Morphology of hBMSC on scaffolds
Morphologies of cells cultivated onto the scaffolds were observed by SEM. At certain
time points of culture (such as day 1 and day 7), scaffolds seeded with cells were washed
twice with PBS, fixed with 3.7% formaldehyde in 100 mM CaCl2 solution for 30 min,
washed with distilled water, and dehydrated using a gradation series of ethanol/distilled
water solutions. Critical point drying was performed with a CPD 030 apparatus (BAL-
TEC AG, Liechtenstein). Dried samples were coated with gold, and observed using a
Philips XL 30/ESEM with FEG, operated in SEM mode.
The cells on alginate/apatite core/shell scaffolds were also observed by confocal laser
scanning microscopy (cLSM). For preparing samples for cLSM, after washing with PBS
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and blocking with 3% bovine serum albumin (Sigma-Aldrich) in PBS, cytoskeleton of
the cells was stained using AlexaFluor 488® phalloidin (Invitrogen, Carlsbad, USA).
The confocal LSM characterization was performed by cLSM (LSI, Macro Confocal,
Leica, Germany) with upright super zoom.
2.2.9.3 Proliferation and osteogenic differentiation of hBMSC on scaffolds
Proliferation and osteogenic differentiation of hBMSC cultivated on the scaffolds were
determined by measurement of intercellular lactate dehydrogenase (LDH) activity and
alkaline phosphatase (ALP) activity, respectively. At different time points of cultivation,
cell-seeded scaffolds were washed twice with PBS and frozen at -80°C until biochemical
analysis. After thawing, the frozen samples were incubated with lysis buffer (1% Triton
X-100/PBS) for 50 min on ice. Cell lysis was supported by sonication for 10 min in an
ice-cooled ultrasonic bath.
The LDH activity was determined in the lysates using the CytoTox 96® Non-Radioactive
Cytotoxicity Assay (Promega, Madison, USA) according to the manufacturer’s
instructions. One aliquot of each lysate was mixed with LDH reaction buffer (Cytotox96
kit, Promega, Madison) and incubated under general shaking for 30 min at room
temperature. The enzymatic reaction was stopped by addition of 1 M acetic acid.
Absorbance was measured at 492 nm (SpectraFluor plus, Tecan) and correlated with the
number of viable cells by using a calibration line.
To measure ALP activity, another aliquot of the lysates was incubated with 1 mg/ml p-
nitrophenylphosphate (Sigma-Aldrich) in 0.1 M diethanolamine (pH 9.8) containing 1%
Triton X-100 and 1 mM MgCl2 at 37°C for 30 min. 1 M of NaOH was added to stop the
enzymatic reaction. After centrifugation at 16,000 g for 10 min, the supernatant was
transferred to a microtiter plate and the absorbance was read at 405 nm. A calibration line
constructed from different dilutions of a 1 mM p-nitrophenol (pNp) stock solution was
used to calculate the amount of pNp produced by the cell lysate which was then related to
the respective cell number to determine the specific ALP activity in µmol pNp/30 min/106
cells.
2.2.10 Bovine serum albumin (BSA) delivery
BSA was selected as model protein to study the protein delivery from the plotted
CPC/alginate scaffolds, as well as from the core/shell scaffolds.
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BSA loading and release from plotted CPC, alginate and biphasic CPC/alginate scaffolds
were performed as follow: BSA was mixed into the material pastes before plotting. For
loading of the alginate paste with BSA, 0.1 g BSA (fine powder) (Sigma Aldrich, USA)
was homogeneously mixed with 0.6 g alginate powder and then added to 3.35 g PVA
(6%) solution to produce a plotting paste as described above. For loading of the CPC paste
with BSA, 0.1 g of fine BSA powder was added to 4.2 g CPC paste and then mixed
vigorously until a homogenous paste was achieved. BSA loaded alginate, CPC and
biphasic CPC/alginate scaffolds (8×8×3 mm3) were plotted and weighted to calculate the
BSA amount of each scaffold. Then, 3 drops of 2 M CaCl2 solution were added on top of
the alginate scaffolds for crosslinking; finally, the scaffolds were dried at room
temperature. CPC scaffolds were incubated in humid environment at 37°C for 2 days
(without submersion in water) for setting and hardening, and then dried at room
temperature. Three drops of 2 M CaCl2 solution were added to the alginate strands of the
biphasic scaffolds, which were then transferred into humidity for setting of the CPC part
of the biphasic scaffolds for 2 days at 37°C. For release experiments, the scaffolds were
incubated in 3 ml PBS (pH 7.4) at 37°C, and at each time point (1, 3, 6, 9, 24, 48, 72, 98
and 144 h), 1.5 ml PBS was taken, centrifuged at 9,300 g for 5.5 min and the supernatant
was used for quantification of released BSA. 1.5 ml fresh PBS was added to each sample.
Measurement of the BSA content was carried out using the Roti®-Nanoquant protein
quantification assay (Roth, Germany) according to manufacturer’s instructions,
absorbance was read at 590 nm and 450 nm (TECAN, Infinite 200 PRO). Four samples of
each scaffold type were analyzed. Scaffolds without BSA loading were used as blank
control.
BSA loading and release from the alginate/apatite core/shell scaffold was performed as
follows. First of all, 100 mg BSA was dissolved in 10 ml 500 mM Na2HPO4 solution and
stirred until BSA dissolved completely, then 1 g alginate powder was mixed with 5.5 g the
solution to prepare plotting pastes and fabricate 3D scaffolds as described in section 2.2.6.
BSA loaded pure alginate and mixed alginate/HAP scaffolds were also fabricated as
control as follows. 100 mg BSA was dissolved in 10 ml deionized water, and then 1 g
alginate powder and mixed alginate/HAP (3/1) was mixed with 5.5 g this water,
respectively. After stirring into homogeneous pastes, the scaffolds were fabricated as
described in section 2.2.6. Afterwards, each scaffold was immersed in 5 ml 1 M CaCl2
solution (pH9.5) for 30 min and washed three times with deionized water. The resulting
CaCl2 solution was collected and analyzed photometrically (UV mini-1240, Shimadzu
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Japan) at 280 nm. The data were used to calculate the BSA loading efficiency. Each of the
BSA-loaded scaffolds was immersed in 6 ml SBF solution (pH7.4) and kept at 37°Ϲ. At
each time point, 3 ml SBF were taken in 15 ml tubes and centrifuged at 4000 rpm for 10
min. The suspensions were taken to quantify the released BSA photometrically at 280 nm,
calculated according to a calibration line, and then 3 ml fresh SBF were added to each
sample. Three samples were tested for each type of scaffold.
2.2.11 Statistical analysis
For all experiments, the data were expressed as mean ± standard deviation (SD). One-Way
ANOVA was performed to analyse the variables and a p-value<0.05 was considered
statistically significant.
2.3 Results and discussion
2.3.1 Calcium phosphate cement (CPC) scaffolds
2.3.1.1 The newly developed CPC pastes and plotting parameters
The new CPC pastes (InnoTERE, Radebeul, Germany) which were prepared by mixing a
calcium phosphate precursor powder with biocompatible oil instead of water or other
aqueous solutions did not to start set and harden until it comes into contact with aqueous
media (such as PBS, SBF) [143], which makes it suitable for storage and extended
plotting.
The pore size, structure and porosity of 3D scaffolds fabricated by 3D plotting was
designed by CAD, and the size of the strands was controlled by the plotting parameters
such as dosing pressure, plotting speed and needle size. Here, the relationship between the
strands size and plotting speed, needle size and dosing pressure was studied. As expected,
strands size decreased with increasing plotting speed and decreasing dosing pressure
(Figure 2.2 & 2.3).
Lower speed and higher pressure lead to overwhelmed strands (much wider than needle
size), and higher speed and lower pressure produced insufficient strands which tended to
be disrupted. Therefore, these parameters (speed, pressure and needle size) should be
carefully selected and have to match each other, to obtain homogeneous strands.
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Figure 2.2: The relationship between plotting speed and the diameter of plotted strands under
different dosing pressures with inner diameter of 0.61 mm (A), 0.4 mm (B) and 0.2
mm (C) by using stainless steel needles.
By varying only the plotting speed (velocity) of the extrusion needle, while holding
constant the needle diameter and the dosing pressure parameters, the width of plotted
strands tracked the governing equation:
(2.4)
D(v) is the resultant strand width, A and B are constants and represent the influence of the
nozzle diameter and the working air pressure, and v is the velocity of the extrusion nozzle.
From our data, it can be seen that A increased with the increase of the needle diameter, as
well as with an increase of the pressure.
By varying only the dosing pressure of the extrusion needle, while holding constant the
needle diameter and the plotting velocity parameters, the width of the plotted strands show
a linear dependence-but only for big needle diameters (>200 µm) and a low plotting
velocity (<10 mm/s). From the obtained data, it can be seen that the linear relationship
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between dosing pressure and strands diameter was less obvious when the needle diameter
decreases and the plotting velocity decreases.
Figure 2.3: The relationship between dosing pressure and the diameter of plotted strands under
different plotting speed with inner diameter of 0.61 mm (A), 0.4 mm (B) and 0.2 mm
(C) by using stainless steel needles.
2.3.1.2 Preparation and characterization of scaffolds
Figure 2.4 illustrates the process of CPC scaffold fabrication by 3D plotting including the
post processing steps. A ready-to-use CPC paste (P-CPC) is filled in a cartridge which is
loaded in the plotting unit. By using compressed air, P-CPC strands are extruded and laid
down to build a CPC scaffold with pre-designed structure (Figure 2.4A and B). After
plotting, the CPC scaffolds are transferred into water or buffered aqueous solutions for
setting and hardening (Figure 2.4C). After drying at room temperature, the CPC scaffolds
can be sterilized by gamma-irradiation prior to their application (Figure 2.4D and E).
Alternatively, the process can be completely performed under sterile conditions – with
setting in cell culture medium at 37°C and without drying in case of incorporation of
A B
C
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living cells or with hardening not in aqueous solution but a humidified atmosphere in case
of loading with growth factors or drugs. Plotted CPC scaffolds with different pore sizes
and morphologies can easily be achieved (Figure 2.4F).
The pore size not only can be controlled by the strand size (pore wall size), but also by
pre-designing the scaffold parameters such as the strand length and the number of the
strands for each layer. Figure 2.5 shows plotted CPC scaffolds with the same strand length
of 10 mm and 20 layers but with different strands numbers per layer, which contributed to
different pore size. Due to the precise regular structures, the pore size was pre-defined and
could be calculated by the strand length, strand size and strand number. Concerning the
calculation, the pore size should be 655 µm, 549 µm, 389 µm and 328 µm for the situation
with a strand length of 10 mm, a strand size of 410 µm and a strand number of 10, 11, 13
and 14, respectively. After scaffolds was plotted and the pore size was measured by
microscope, the data showed that the real pore size was 605±7 µm, 543±10 µm, 390±18
µm and 323±5 µm when the strand number was 10, 11, 13 and 14, respectively. The real
scaffolds therefore matched the size of the pre-defined CAD model.
Figure 2.4: The process of preparing CPC scaffolds by 3D plotting
In addition, Figure 2.5 presents the microscope images of CPC scaffolds before and after
incubation in water (for setting) and drying. Before incubation in water, the surface of the
plotted CPC scaffolds were light reflective, which of course was caused by the
incorporated oils. However, after setting in water for several days and drying, the surface
of CPC scaffolds were not reflective any more. The phenomena indicated that during
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The other way is the application of a temporary material for filling the space between the
CPC strands and therefore supporting the structure during the plotting process. This
sacrificial material should be injectable to enable plotting with the same device and water
soluble so that it can be dissolved during setting and hardening of the CPC scaffold in
water to unblock its macroporous structure. We adopted a 25 wt% PVA paste as
temporary material since it fulfills these requirements and obtained CPC scaffolds which
kept their shape and whose pores oriented parallel to the x- and y-axes were completely
open and uniform. In contrast, the pores of scaffolds fabricated from the same P-CPC
material but without sacrificial PVA strands were partially closed (Figure 2.8). The
stabilizing effect of the PVA supporting strands is not only caused by simple filling of the
space between two CPC strands, but also due to the fact, that the PVA paste contains
water which permeates the CPC strands and triggers the cement setting reaction. This
phenomenon results in a graded increase of stiffness of the layers from the bottom up as a
function of contact time between CPC strands and water from PVA sol. Deformation of
the scaffolds including closure of the macropores in x/y-direction described above (Figure
2.8B) is caused by gravitational force, which is effective especially in case of a
considerable difference in the density of plotting material (P-CPC) and plotting medium
(air). Therefore, an alternative method might be plotting of P-CPC into water or cell
culture medium to minimize this difference in density. In this case, the CPC strands would
harden immediately after extrusion and thereby achieve an increased stiffness which
should be sufficient to support the weight of the whole scaffold resulting in uniform and
open pores in x-/y-direction. However, problems concerning the weak bonding between
the several layers and potential blocking of the printing nozzle are still unresolved.
Figure 2.8: CPC scaffolds with (A) and without (B) PVA pastes as sacrificed support
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CAD/CAM enables the fabrication of CPC scaffolds with different size and shape by
using 3D plotting technique, not only with respect to the overall shape that fit into a
patient-specific defect but also with an optimized inner pore size and structure to support
cell attachment and migration as well as blood capillary ingrowth on the one hand and to
mediate adequate mechanical stability on the other hand. As shown in Figure 2.5F, CPC
scaffolds with designed pore size and morphologies can be fabricated by using the 3D
plotting technology illustrating the key advantage of RP techniques – compared to
conventional methods used for scaffold preparation – namely the control and optimal
adjustment of pore parameters such as size, distribution and morphology. The strong
influence of size and morphology of the pores on scaffold performance concerning
mechanical properties, cellular response and new bone formation in vivo has been
demonstrated in many studies [74-81]. In addition, a complete interconnectivity of the
pores, which is also necessary for cell growth and migration and homogeneous new bone
formation in the scaffold, was achievable by using the 3D plotting technique.
One important issue with respect to tissue engineering applications is the resolution of
plotted scaffolds as it has a strong influence on pore size and structure. The resolution
depends mainly on characteristics of the basal material (e.g. molecular weight of
polymers, particle size of ceramic powder, composition of composites etc.) and on the
properties of the respective pastes prepared for plotting (such as viscosity and
homogeneity). Critical factors and parameters which affect the viscosity and therefore the
resolution of plotted scaffolds are the solid/liquid ratio and temperature (in case of
polymer melts). In our work, the cement particle size has been reduced by optimization of
the grinding procedure during preparation of the P-CPC that resulted in a clear
enhancement of the resolution achieved by application of finer nozzles: CPC strands of
less than 200 µm width can be plotted (Figure 2.9A).
The microscopic images depicted in Figure 2.9 demonstrate the performance of the new
technique of CPC plotting for scaffold fabrication. Plotting of the optimized P-CPC with
nozzle diameters of 200 and 410 µm, respectively, lead to a uniform pore size and
consistent pore structure. Moreover, CPC scaffolds possessing an anisotropic structure –
one example is shown in Figure 2.9B and D – can also be fabricated with this technique.
In that scaffold, a denser part with smaller pore size and lower porosity for mimicking
compact bone and a less dense part with bigger pore size and higher porosity mimicking
trabecular bone were designed and fabricated, leading to a distinct anisotropic material.
On the other hand, some studies have shown that scaffolds with small pores favor hypoxic
conditions and induced osteochondral
pores, that can be better
anisotropic structures with gradients in pore size would be recommended for the formation
of multiple tissues and tissue interfaces such as biphasic scaffolds fo
osteochondral defects.
Figure 2.9
2.3.1.3
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In case of scaffolds fabricated by RP technologies, the influence of macroporosity and
scaffold architecture, predefined by the CAD data set, on mechanical strength has been
clearly demonstrated by several studies [144-146]. The mechanical properties of the
plotted CPC scaffolds are – to a certain extent – adaptable by design and changing of the
pore parameters. Generally, a uniform and continuous pore structure and orientation
improves the mechanical strength [147, 148] and with this respect, scaffold fabrication
applying the technique of 3D plotting has advantage over other conventional methods.
Figure 2.10: Compressive strength (A) and modulus (B) of plotted CPC scaffolds with different
porosity (variation due to different strand numbers). Scaffolds with a size of 10 mm
× 10 mm × 10 mm were tested. (*P<0.05).
The 3D plotted CPC scaffolds set in water were mechanically weaker than those sintered
at high temperature. We studied the modulus of the plotted CPC scaffolds with and
without sintering and found that the plotted CPC scaffolds produced with an additional
sintering step (1250°Ϲ for 3 h) acquired a modulus of about 330 MPa, which is nearly 7
times higher than that of samples with the same geometry produced without sintering
(Figure 2.11A). As apparent from SEM investigations (Figure 2.11B and C), high
temperature sintering results in highly crystalline materials with – compared to cements –
bigger particles which are connected to each other by sinter necks. This structural feature
is accompanied by a higher mechanical strength. In contrast, CPC consists of smaller,
mostly nanocrystalline particles which were formed and became entangled during the
precipitation reaction providing mechanical rigidity [149]. Accordingly, the SEM image
shown in Figure 2.11 reveals that the surface of the non-sintered CPC strands is highly
porous with a plenty of small particles which seem to be bonded weaker compared to the
more dense counterparts produced by sintering.
*
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Figure 2.11: Young’s modulus of the scaffolds with and without sintering is shown (A). SEM
images demonstrate the microstructures of CPC scaffolds (porosity 49%) without
(B) and with (C) sintering at 1250°Ϲ for 3h. (*p<0.05). Scaffolds with a size of 10
mm × 10 mm × 10 mm were tested.
Most porous calcium phosphate bioceramic scaffolds are produced or at least post-treated
at high temperatures since the high crystallinity and increased density induced by the
sintering strongly enhance the mechanical properties. On the other hand, the
biodegradability of such materials is limited [150] and the incorporation of drugs, growth
factors or autologous components is possible only after fabrication of the scaffold. CPC
does not require post-sintering to achieve stable structures and it can set and harden under
mild conditions – according to the requirements in water or a humidified environment. In
addition, due to free spaces between precipitated crystals, calcium phosphate bone
cements exhibit a high intrinsic microporosity and the resultant large surface area is
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beneficial for drug loading [150]. The nanocrystalline structure of CPC finally allows their
resorption by osteoclasts and remodelling into new bone tissue [151, 152].
A new founding according to the improvement of mechanical properties of plotted CPC
scaffolds is to set the scaffolds in a humid environment instead of incubation in water
directly. In a new study, we proved that the mechanical strength was increased two times
after setting in humidity for 2 days and then in a water bath for 1 day (37°Ϲ) compared to
the scaffolds setting in the regular process (setting in water for 3 days at 37°Ϲ). One of the
main reasons is that setting of the ready-to-use CPC in humidity can reduce the micro-
cracks and therefore porosity in the strands.
2.3.1.4 Cell culture
Another important feature of a scaffold developed for tissue engineering applications is its
performance as cell carrier. We have seeded hBMSC, derived from bone marrow, on the
plotted CPC scaffolds to evaluate their cytocompatibility [24]. The cell-seeded scaffolds
were cultivated over 19 days in cell culture medium containing osteogenic supplements
(dexamethasone, β-glycerophosphate and ascorbic acid 2-phosphate) which are able to 
induce the differentiation of hBMSC into osteoblasts in vitro. SEM analyses revealed that
the cells attached to and spread over the surface of the plotted CPC scaffolds (Figure 2.12
A and B).
After longer cultivation time, the cells proliferated and migrated, even bridging the gaps
between the CPC strands (Figure 2.12C) and finally formed a thick cell sheet (Figure
2.12D). Proliferation and differentiation along the osteoblastic lineage were evaluated by
biochemical determination of the enzyme activities of LDH, a housekeeping enzyme
whose activity can be correlated with the number of living cells, and of ALP, a typical
marker of the early stage of osteoblastic differentiation. LDH activity measurement
revealed that the number of viable cells increased over the cultivation period (Figure
2.12E). The rise of the specific ALP activity with a maximum value at day 12 strongly
indicates the osteogenic differentiation of hBMSC cultivated on the CPC scaffolds in the
presence of osteogenic supplements (Figure 2.12F). The data of the cell experiment
demonstrated the capability of the plotted CPC scaffolds to support hBMSC attachment,
growth and osteoblastic differentiation.
2. Calcium phosphate (CaP) and CaP/alginate scaffolds
41
Figure 2.12: SEM images of hBMSC cultured on plotted CPC scaffolds on day 6 (A, B) and day
12 (C, D). Cultivation of hBMSC on 3D plotted CPC scaffolds in the presence of
osteogenic supplements. Cell number was quantified by measurement of LDH
activity (E). Specific ALP activity was determined by measurement of ALP activity
and relation to the cell number determined for the same lysates (F) (n=3, mean ±
SD). (Performed by Dr. Anja Lode).
2.3.2 Alginate scaffolds
2.3.2.1 Preparation of scaffolds
Alginate was selected in this work due to its positive characteristics, such as generally
good biocompatibility and biodegradation as well as the ability of gelation with divalent
cations under mild conditions (room or physiological temperature and aqueous solution)
[50]. It has been used extensively for biomedical engineering. Most of these produces
2. Calcium phosphate (CaP) and CaP/alginate scaffolds
42
(such as alginate microspheres, hydrogel and scaffolds) were prepared from low
concentrated alginate sol (0.5-4 wt %). However, such scaffolds suffer severe shrinkage
after drying and had low mechanical strength. For bioplotting, low concentrated alginate
sols tended to diffuse after extruding through fine needles and they were not able to
support the whole 3D structure of a scaffold during plotting. Therefore, such alginate sols
have to be plotted into calcium ions containing solutions to keep the regular shape of the
strands [153, 154]. However, there were two main shortages by plotting alginate sol in
calcium ions containing solution. One is that the plotting needles tended to be blocked due
to the potential contact of the plotting needle with the solution and crosslinking alginate
already in the needle. The other is weak binding of alginate strands between the layers of
scaffold because of the inhomogeneous crosslinking.
Herein, in this work, concentrated alginate pastes were developed by mixing sodium
alginate powder with PVA solution in a certain mass ratio. PVA is a water-soluble
synthetic polymer, which is also biocompatible and has been used a lot in tissue
engineering and regeneration medicine as hydrogel and scaffolds [155-157]. The prepared
concentrated alginate/PVA pastes were homogeneous and suitable by extruding through
fine needles leading to stable strands. The plotted scaffold was able to keep the regular
shape of the strands and uniform structure of 3D scaffold while plotting in air (Figure
2.13) and not only when fabricated in calcium ions containing solution, compared to that
prepared by the low concentrated alginate sols.
Table 2.1.: The parameters of plotted alginate/PVA scaffolds
Alginate/
PVA
Alginate
concentration
PVA
solution
(g)
PVA
concentration
(w/v)
Water
content
(g)
(alg+PVA)/
water
Plotting
pressure
(Bar)*
3/1 18.2% 5.5 6% 5.17 1/4 5.6
2/1 15.4% 6.5 7,7% 6.0 1/4 4.1
1/1 12.5% 8.0 12,5% 7.0 1/4 3.2
1/0 18.2% - - 5.5 1/5,5 4.5
*Inner diameter of needle was 0.61 mm and plotting speed was 4 mm/s.
After the whole scaffold was fabricated, it had to be transferred to calcium ions containing
solution for crosslinking of alginate. By this way, alginate scaffold was cosslinked
homogeneously and the alginate strands between layers were strongly bond together. With
the decrease of alginate content in the prepared paste (decrease of alginate concentration),
the required plotting pressure was also decreased. However, the lower concentration of
alginate
struct
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alginate/PVA strands provided clear information about these differences. From these SEM
images it can be seen that the surfaces of alginate/PVA scaffolds were rougher than that of
a pure alginate scaffold, and there were some micropores on the surface of alginate/PVA
scaffolds compared to the pure alginate scaffold with a very dense surface and without any
micropores. Also the inner strands of alginate/PVA scaffolds were porous and numerous
micropores were observed, while the inner strands of pure alginate scaffold were very
dense and compact (Figure 2.14).
Figure 2.14: Optical microscopical (A, B, C and D) and SEM images showing the surface (E, F, G
and H) and cross-sections (I, J, K and L) of plotted scaffold strands with different
alginate/PVA ratio: 1/1 (A, E and I), 2/1 (B, F and J), 3/1 (C, G and K) and 1/0 (D,
H and L). Scale bar = 20 µm for SEM images.
On the other hand, the added PVA was almost removed from the alginate scaffolds after
incubation in CaCl2 solution for several hours, which can be confirmed by FTIR analysis.
FTIR analyses were performed on the alginate/PVA (3/1) and pure alginate scaffolds after
crosslinking (incubating in CaCl2 solution for 5 h) and drying. From the obtain data, it can
be seen that the FTIR spectra of these two scaffolds were quite similar (Figure 2.15) and
the identification peaks of PVA were not observed in the spectra (such as absorption
bands at 1750-1735 cm-1 and 2840-3000 cm-1) [158], which indicated that the PVA was
almost completely removed from alginate scaffolds.
E F G H
I J K L
A B C D
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Figure 2.15: FT-IR spectra of an alginate/PVA (3/1) (A) and a pure alginate (B) after incubation
in CaCl2 solution for 5 h and drying.
The produced micropores in alginate/PVA significantly increased the specific surface area
and decreased the density compared to pure alginate scaffolds without micropores (Figure
2.16A). The increased specific surface area facilitated for protein adsorption and
water/medium infiltration. From the obtain data, it can be seen that alginate/PVA scaffolds
showed 180% to 500% water adsorption, which was significantly higher than that of pure
alginate scaffolds (only 50% water adsorption) during incubating in PBS for 5 h (Figure
2.16B).
Figure 2.16: Density of alginate/PVA scaffolds, which was calculated by weight and volume of
scaffolds (density = weight/volume) (A). Water adsorption of alginate/PVA
scaffolds after incubating in PBS at 37°Ϲ (B).  
B
A
A B
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2.3.2.3 Degradation in vitro
The degradation behavior of plotted alginate/PVA scaffolds was studied by incubating
scaffolds in SBF at 37°Ϲ over 42 days. Weight loss was calculated and is presented in 
Figure 2.17. The data indicated that alginate scaffolds with or without PVA had less than
12% weight loss after incubation in SBF over 42 days. The weight loss increased with the
increase of PVA in alginate scaffolds. Interestingly, weight loss for all scaffolds increased
in the first 14 days (d 1-d 14), but decreased after incubation in SBF in the following 14
days (d 14-d 28) and then increased again in the last 14 days (d 28-d 42). This can be
explained by apatite deposition on the surface of scaffolds after incubation in SBF over 14
days, which then increased the weight of scaffolds. SEM image taken of scaffolds after
storage in SBF for 28 days have shown apatite formation on the surface. The again
increasing weight loss of alginate/PVA scaffolds after incubation in SBF over 28 days
would be related with the degradation of alginate after long time soaking and the loss of
crosslinker (calcium ions) from scaffold. Scaffolds were able to keep their regular
structures after soaking in SBF over 42 days, although severe swelling happened due to
rich water adsorption.
Figure 2.17: Weight loss of alginate/PVA scaffolds after incubation in SBF over 42 days (A), and
SEM picture of the surface of an pure alginate scaffold after soaking in SBF for 28
days (B). The white particles are precipitated calcium phosphate mineral phases.
The degradation ratio and behavior of alginate scaffolds not only depended on the
properties of alginate (such as molecular weight and composition), structure of the
scaffolds (such as microstructure), but also depended on the environment of the solution
(such as pH and ions) [159]. For example, alginate scaffolds degraded much faster in PBS
A B
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than in SBF because of the fast calcium exchange and the lack of apatite deposition ability
in PBS.
2.3.2.4 Mechanical tests
The compressive strength and modulus of the plotted scaffolds with high porosity were
tested in dry and wet state. From the obtained data (Figure 2.18), it can be seen that the
pure alginate scaffolds (1:0) have significantly higher compressive strength and modulus
than alginate/PVA scaffolds (1:1, 2:1 and 3:1) in both dry and wet state. Compressive
strength and modulus of alginate/PVA scaffolds were decreased with increasing PVA
content. The presented micropores in alginate/PVA scaffolds are the main explain for the
decrease of the mechanical properties compared to pure alginate scaffold. The micropores
decreased the density of the scaffolds, which in turn decreased the mechanical strength.
However, in pure alginate scaffolds, the alginate strands were very dense. Therefore, the
compressive strength and modulus of pure alginate scaffolds were as high as 20.7±4.1
MPa and 127.4±24.5 MPa in dry state, respectively. The mechanical properties of the
scaffolds decreased sharply in wet state compared to dry state for both alginate/PVA and
pure alginate scaffolds, such as the compressive strength of pure alginate scaffold was
0.85±0.07 MPa, less than 5% of that in dry state.
Figure 2.18: Compressive strength (A, B) and modulus (C, D) of scaffolds with different
alginate/PVA ratio in dry (A, C) and wet (B, D) states (15% strain achieved).
Scaffolds (dry) with size of 6 mm × 6 mm × 6 mm were tested. (*p<0.05).
A B
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Pure alginate or alginate/PVA scaffolds prepared with concentrated pastes showed about
35% shrinkage after drying due to the loss of water. However, scaffolds suffered no
deformation and still maintained their regular structures as in wet state. Alginate fibers
were bound closely by calcium ions after crosslinking and entangled physically after
drying, which resulted in very dense alginate strands and then finally contributed to the
excellent mechanical properties. However, in wet state (such as in SBF or in cell culture
medium), alginate scaffolds swelled due to the efficient water adsorption. Then the
entangling between alginate fibers was loosened and the crosslinking calcium ions were
partly exchanged, which significantly reduced the stiffness of the alginate strands and
finally decreased the mechanical properties of the whole scaffolds.
However, the alginate scaffolds prepared in our study have significantly higher
mechanical strength and modulus than those prepared by other methods and with low
concentrated alginate sols [75, 160-162]. There are two advantages contributing to the
improved mechanical strength of our scaffolds. One is the uniform and continuous pore
structure; the other one is the usage of highly concentrated alginate pastes that resulted in
a stronger gel structure after being crosslinked. In addition, these two advantages make the
scaffolds undergoing only little deformation and forming more stable structures after
drying, compared to those prepared by other methods and using low concentrated alginate
sols.
2.3.3 Biphasic CPC/alginate scaffolds
2.3.3.1 Preparation of scaffolds
Ceramic and polymer scaffolds developed for bone tissue engineering applications have –
defined by their intrinsic properties – specific advantages and disadvantages. For instance,
the low mechanical strength and inherent brittleness of pure calcium phosphate scaffolds
prepared without sintering remain limitations for their clinical application. The
development of ceramic/polymer composite scaffolds is a promising option to generate
structures of enhanced quality with respect to their mechanical properties [163]. Such
organic/inorganic composite scaffolds mimic the natural bone to some extent since bone is
likewise composed of an inorganic (hydroxyapatite) and an organic biopolymer part
(mostly collagen type I). Due to its composite character, bone is perfectly adapted to
compression, tension, bending and torsion.
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This part describes two different types of CPC/alginate composite scaffolds. Beside
monophasic composite scaffolds prepared of a mixed CaP/alginate paste, biphasic
structures are fabricated through simultaneous plotting of a CPC and an alginate paste
demonstrating the option to generate bipartite organic/inorganic scaffolds with a
predesigned structure adapted to special requirements of complex tissue defects. The
consistency of the novel concentrated alginate/PVA pastes (described in the previous part)
is comparable to those of the P-CPC enabling simultaneous processing of both pastes in
one and the same scaffold. This alginate/PVA paste can support the whole structure of the
printed scaffold without deformation. In addition, just as indicated in the previous part, in
contrast to the less viscous low concentrated alginate sols, the viscosity of the highly
concentrated alginate/PVA paste is high enough to allow plotting in air instead of in a
CaCl2 solution as it would be necessary otherwise to stabilize the structures immediately
after extrusion. This is an important prerequisite for plotting in combination with the P-
CPC and can avoid problems, caused by extrusion into a CaCl2 bath such as blocking of
the nozzle during the manufacturing process and inhomogeneous crosslinking of the
scaffold with incomplete or no bonding between the strands.
In Figure 2.19, the CAD models of both composite scaffold types and the real objects
achieved by the 3D plotting process are shown. The photographs demonstrate that the
designed biphasic CPC/alginate scaffold with P-CPC and alginate strands plotted
alternately was successfully realized. The strands of the different layers were bond closely
among each other due to the homogeneous crosslinking of alginate and setting of CPC.
The biphasic scaffolds were further stabilized by interpenetration of the crosslinked
alginate and hardened CPC strands between the layers. Micrographs show the regular
structure and organization of CPC and alginate strands which are weaved alternatively
forming an interpenetrating structure consisting of an alginate and a CPC grid with
macropores, open in all directions. As control, mixed CaP/alginate scaffolds were also
designed and fabricated successfully with the same designed parameters as the biphasic
CPC/alginate scaffolds.
As it is known that CPC set and harden without any dimensional change [164], no
significant change of size was recognized for the pure CPC scaffolds after drying. In
contrast, pure alginate and mixed CaP/alginate scaffolds underwent shrinkage in x, y and z
directions to a different extent during drying due to the loss of water from alginate pastes.
Scaffolds printed from highly concentrated alginate also undergo shrinkage to a certain
degree but without deformation – in contrast to scaffolds prepared from low concentrated
alginate sols which suffer from severe shrinkage
the biphasic CPC/alginate scaffolds, only the alginate strands shrunk and were thereby
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Table 2.2.: Parameters of the 3D plotted scaffolds (20 layers)
sample Shrinkage
X, Y (%)
Shrinkage
Z (%)
Pore size X,
Y (µm)
Pore size
Z (µm)
Porosi
ty (%)
CPC - - 827±93 413±70 48.8±
1.3
Biphasic - - 895±204 653±104 72.7±
8.5
Mixed 13.1±2.2 23.5±1.8 792±48 422±42 70.8±
6.6
Alginate 24.3±0.6 36.3±1.4 435±48 294±57 60.3±
5.8
2.3.3.3 Mechanical tests
The mechanical properties of the plotted biphasic CPC/alginate and mixed scaffolds in
comparison to pure CPC and alginate scaffolds were tested in dry and wet state (Figure
2.22). The compressive strength of both biphasic CPC/alginate and mixed scaffolds was
almost two times that of pure CPC ones in dry state. After soaking in SBF for 2 hours, the
compressive strength of pure alginate and mixed CaP/alginate scaffolds decreased
strongly to values which were significant lower than that of biphasic CPC/alginate and
pure CPC scaffolds. In contrast, compressive strength of biphasic scaffolds was still
significantly higher than that of pure CPC scaffolds after soaking. The compressive
modulus of alginate scaffolds in wet state was only 1.8 MPa and the incorporation of CPC
powder into alginate (mixed CaP/alginate scaffolds) resulted only in a limited increase of
the modulus to 2.6 MPa, which is significantly lower than that of both the pure CPC and
the biphasic CPC/alginate scaffolds.
Figure 2.22 C showed that the stress of pure alginate and mixed CaP/alginate scaffolds
increased with the compressive deformation and the scaffolds still held the bulk
morphology without collapsing in dry state. Stress of pure CPC scaffolds increased
sharply with compression at the beginning and then fell quickly to zero after the maximum
value as the scaffold was broken into small fragments. In contrast, the compressive
strength of the biphasic CPC/alginate scaffolds increased almost linearly with the
deformation at the beginning, reached a maximum value which is twice as high as that of
pure CPC scaffolds and occurred at higher strain. After 35% compressive deformation was
performed, the biphasic CPC/alginate scaffolds still maintained their bulk morphology
instead of cracking into powder as observed for pure CPC ones.
Figure 2.2
Just by simple combination of the two materials in the same plotting process and without
additional steps, scaffolds with new properties, clearly differing from that constructed of
the pure materials, have been created.
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compared to monophasic scaffolds. This situation is different from plotting low
concentrated alginate sols with other materials. For example, Lee et al. [165] fabricated
polymer hybrid scaffolds by printing PCL and low concentrated alginate (3.5%) separately,
which exhibited better mechanical properties than pure alginate scaffolds but lower than
pure PCL scaffolds, due to the fact that PCL is significant stronger regarding mechanical
strength than the low concentrated alginate hydrogel.
2.3.3.4 Cell culture
Cell culture experiments performed in vitro are able to provide information concerning
cytocompatibility being the first step of evaluating the performance of a novel type of
scaffold for tissue engineering and regenerative therapies. As already demonstrated, CPC
scaffolds are good candidates supporting the attachment, growth and osteogenic
differentiation of hBMSC. Cytocompatibility of both the biphasic and mixed CaP/alginate
composite scaffolds in comparison to the pure CPC ones was evaluated by seeding of
hBMSC on the plotted structures. The cell-seeded scaffolds were cultured over a period of
three weeks with or without osteogenic supplements. The morphology and distribution of
the cells attached to the scaffolds were observed by means of SEM: one and seven days
after seeding, hBMSC were attached and well spread on the surface of the biphasic
CPC/alginate as well as mixed scaffolds (Figure 2.23).
Interestingly, in the course of further cultivation differences have been found: while viable
and well spread cells were detected on pure CPC and biphasic CPC/alginate scaffolds,
both in the presence and in the absence of osteogenic supplements, the number of cells
cultivated on mixed CaP/alginate scaffolds was strongly reduced, but only in the presence
of osteogenic supplements, as indicated by SEM analysis and determination of cytosolic
LDH activity (as measure for the number of living cells). This phenomenon might be
caused by the apatite formation on the surface of mixed CaP/alginate scaffolds that was
observed to start on day 1 of culture resulting in an intense deposition of apatite particles
as observed after 7 days of culture (Figure 2.23 B, E and H). A potential reason for the
strong apatite precipitation on the mixed CaP/alginate scaffolds was the high degree of
supersaturation due to the hydrolysis of CPC particles (mostly α-TCP) and both calcium 
ion exchange from the Ca2+-crosslinked alginate and the elevated local phosphate ion
concentrations because of the presence of beta-glycerophosphate and ALP producing cells
at the same time [166].
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Figure 2.23: SEM images of hMSC cultivated on scaffolds for 1 day (A, B, C and D) and 7 days
(E, F, G and H), the latter in the presence of osteogenic supplements. Cells on a
CPC (A and G) and an alginate (D) strand of a biphasic CPC/alginate scaffold, cells
on a mixed CaP/alginate scaffold (B and E), and on a CPC scaffold (C and F), and
(H) a high magnification image of the deposited particles on strands of a mixed
scaffold are shown. (White arrows in (B) indicate the formed apatite layer and black
arrows the attached cells).
Growth and differentiation of cells on scaffolds with or without presence of osteogenic
supplements were investigated for 3 weeks by measuring the LDH and specific ALP
activity, respectively. Figure 2.24 of the obtained data showed that the cell number
increased slightly on almost all scaffolds in 3 weeks, except the mixed scaffolds with
osteogenic supplements, in which cell number decreased.
The reason for the decrease of cell number on mixed scaffolds in presence of osteogenic
supplements was the strong apatite deposition on the surface of the mixed scaffolds, which
have already been observed by SEM analysis. In addition, mixed alginate/CaP scaffolds
were unstable and easy to be degraded in cell culture medium due to the weak crosslinking
of alginate (by interruption of the incorporated CPC powder). Specific ALP activity data
showed that the induced hBMSC expressed higher ALP activity compared to non-induced
hBMSC on all three kinds of scaffolds, and a significant increase of ALP activity of
induced hBMSC on pure CPC scaffold compared to the other two composite scaffolds
after 3 weeks of culture. CPC scaffolds have been broadly demonstrated as excellent
candidates for bone tissue engineering due to their pot
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for building of biphasic and mixed alginate/CPC scaffolds that took place under nearly
physiological conditions. The integration of proteins into scaffolds during the plotting
process was evaluated by mixing of bovine serum albumin (BSA) – as model protein –
into the pastes which were used to produce pure alginate, pure CPC and mixed
alginate/CPC scaffolds, respectively. The initial burst of release within the first 9 hours
was determined to be lower than 30% for CPC and 70% for alginate scaffolds. Later on, a
sustained release behaviour has been observed for those three scaffold types, but with
considerable differences with respect to the amount of released BSA. The pure CPC
scaffolds released clearly smaller amounts of BSA signifying that the main part of BSA
remained bound to the calcium phosphate matrix. In contrast, much higher amounts of
BSA were released from the pure alginate scaffolds. The biphasic scaffolds had a
sustained release with a release amount lower than sole alginate but higher than sole CPC
scaffolds. In this study, about 30% of BSA was loaded in alginate part and 70% in CPC
part in the biphasic scaffolds, which indicated that the BSA release amount from the
biphasic scaffolds was close to that of sole CPC scaffolds. The release amount of proteins
from biphasic CPC/alginate scaffolds therefore was corresponding to loading amount of
BSA in CPC and alginate strands (Figure 2.25).
Figure 2.25: BSA release profiles from the plotted scaffolds in PBS solutions at 37°Ϲ and pH 7.4.  
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In this study, BSA was directly mixed in to the materials without covalent bond, so the
release behaviour from plotted scaffolds was suggested as diffusion-based, which is
mainly related to the properties of the matrix, such as porosity and degradation rate. The
pure CPC scaffolds released clearly smaller amounts of BSA signifying that the main part
of BSA remained bound to the calcium phosphate matrix. In contrast, much higher
amounts of BSA were released from the pure alginate scaffolds because of the high
nanoporosity of the hydrogel, quick degradation of alginate scaffolds as well as the low
protein binding capacity of alginate in general. But the BSA release amount is controllable
by alerting the loading amount of BSA in alginate and CPC phases. It definitely can be
speculated that the release of proteins from biphasic CPC/alginate scaffolds can be
controlled by altering the loading amount of BSA in CPC and alginate strands.
2.3.3.6 Bi-partite scaffold for repair of osteochondral defects
By using the multi-channel 3D plotting technique and based on the plotted CPC/alginate
biphasic scaffolds, an enhanced bipartite scaffold with separate layers suitable for repair of
defects at tissue interfaces can be developed. Figure 2.26 presents the CAD model and the
plotted organic/inorganic bi-layered scaffold designed for regeneration of osteochondral
tissue. The bi-partite scaffold consists of a CPC/alginate biphasic layer and pure alginate
layer. The alginate layer was suggested for the repair of chondral part and the
CPC/alginate biphasic layer for the repair of bony part. The SEM pictures showed that the
interface between the two types of layers was bond tightly due to the crosslinking and
interlocking of alginate between the two layers.
One of the main adaptations for preparing such osteochondral organic/inorganic scaffolds
was the integrity and stability between these two parts. To ensure that both layers are
tightly connected to each other, they have to be plotted simultaneously and some of the
strands of the organic phase have to penetrate the other (composite) layer realizing a
mechanically stable interlocking of both materials. The two layers were tightly connected
by the crosslinking of alginate strands between the two layers. The compressive behavior
of the complex bi-partite scaffolds in dry state was measured and found to be sufficient for
possible clinical applications. Compressive strength of the scaffold increased linearly with
the deformation (strain) until a break appeared at 30% deformation and a compressive
strength of 25 MPa.
2. Calcium phosphate (CaP) and CaP/alginate scaffolds
59
Figure 2.26: CAD model (A) and photographs (B) of plotted bipartite scaffolds for repair of
osteochondral defects. SEM image of the cross-section of such a scaffold, the red
line indicates the interface between the two phases: chondral part top and bony
part bottom (C). The alginate strands appear dark grey and the CPC strands white.
High magnification SEM image showing the strong binding between alginate
strands of different layers (D).
2.3.4 Alginate/apatite core/shell scaffolds
2.3.4.1 Preparation of scaffolds
The mineralized pastes prepared by mixing alginate powder with an aqueous Na2HPO4
solution with an alginate content of 15.4 wt % were excellently injectable and stable after
plotting into scaffolds. When the plotted scaffolds were transferred into CaCl2 solution
(pH 9.5), milky white layers were formed as a shell on the surface of the scaffolds, as well
as in the solution immediately. However, when soaking pure alginate and mixed
alginate/HAP scaffolds (mixed with deionized water instead of Na2HPO4 solution) in a
CaCl2 solution no apparent visible changes occurred and the solution remained clear.
When incubating the alginate scaffolds with phosphate precursor in a CaCl2 solution,
calcium was consumed both by alginate gelation and by calcium phosphate formation.
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2.3.4.2 Characterization of scaffolds
Digital photographs and microscopical images (Figure 2.27 and Figure 2.28) of dry
scaffolds showed that the appearance of pure alginate scaffolds was brown, mixed
alginate/HAP scaffolds were white and the HAP particles were clearly observed
embedded in the alginate strands. However, mineralized scaffolds at pH 5 were covered
by brushite layers and mineralized scaffolds at pH 9.5 were covered by a layer of nano
hydroxyapatite. The mineral formation reaction was not only depended on the Ca/P ratio,
but also influenced by the pH value of the reaction solution. Generally, a low pH value
(such as pH 5) contributed to the formation of brushite, high pH value (such as pH 9.5)
resulted in the formation of hydroxyapatite [167].
Figure 2.27: Photograph of a plotted alginate/apatite core/shell (A), mixed alginate/HAP (B) and
pure alginate (C) scaffold.
SEM images revealed that the fabricated scaffolds had only opened and interconnected
pores in all directions. High magnification SEM showed that the mineralized alginate
scaffolds prepared at pH 9.5 were completely coved by a layer of needle-like nano-apatite
crystals on the surface. The core-shell structures with an alginate core and apatite shell of
about 34 µm thickness were observed clearly (Figure 2.29). EDS analyses of the rough
mineralized surface of these scaffolds showed strong calcium and phosphate signals.
In contrast, the surface of pure alginate scaffolds was smooth and dense (Figure 2.30A, D
and G) and EDS analysis only showed calcium but no phosphate peak, while mixed
alginate/HAP scaffolds were rougher and the HAP spread on and embedded in the alginate
strands (Figure 2.30B, E and H). However, micro sized sheet-like brushite and nano sized
rose-like apatite crystals were deposited on the surface of mineralized alginate scaffolds at
pH 5, but the scaffolds possessed no clear core-shell structure (Figure 2.30C, F and I).
A B C
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Figure 2.28: Microscope images of pure alginate scaffolds (A), mixed alginate/HAP scaffolds (B),
and alginate mineralized in situ at pH 5 (C) and pH 9.5 (D), scale bar = 500 µm.
Figure 2.29: SEM images of an alginate/apatite core/shell scaffold mineralized in situ at pH 9.5 in
different magnifications (A-E) and EDS analysis (F).
Micro-CT also gave sufficient information about the prepared core/shell scaffold. From
the obtained µ-CT images, it can be clearly seen that the pores of the scaffold were
completely open and interconnected. A layer of X-ray dense, calcium phosphate rich
composite covered the entire surface of the scaffold (Figure 2.31).
A B C
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Figure 2.30: SEM images of a pure alginate scaffold (A, D and G), mixed alginate/HAP scaffold
(B, E and H) and alginate/CaP scaffold mineralized at pH 5 (pH was not adjusted)
(C, F and I). Images A-C show cross sections and D-I show high magnification on
the respective surface. Insert graphs in G and I demonstrate the EDS analysis.
Figure 2.31: Micro-CT analysis of an alginate/apatite core/shell scaffold. Scale bar = 1 mm.
(Performed by Dr.-Ing. Helene Rahn)
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XRD and FTIR were applied to further characterize the scaffolds, and the data indicated
that the characteristic XRD peaks for HAP were observed in the XRD pattern of the
mineralized alginate in pH 9.5 (Figure 2.32). As control, the XRD pattern of bare alginate
without any apparent characteristic peaks is also presented. FTIR studies showed that The
P-O bands (560 and 600 cm-1) were clearly observed in the mineralized alginate scaffolds
prepared at pH 9.5 compared to the pure alginate ones (Figure 2.33). Both of these
indicated that the prepared mineral layer on the alginate scaffold was HAP.
Figure 2.32: XRD patterns of pure alginate (a), alginate mineralized in situ (b) (pH 9.5) and pure
HAP (c). (Performed by Dr. Michael Ruhnow).
Figure 2.33: FTIR spectra of alginate mineralized in situ (pH 9.6) (a) and pure alginate scaffolds
(b).
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Alginate scaffolds underwent certain shrinkage during drying due to the loss of water.
Here, we also characterized the shrinkage of the mineralized alginate scaffolds and the
results revealed that they suffered lighter shrinkage and deformation than pure alginate
ones, which was related with the formed apatite layers, stabilizing the strands (Figure
2.34).
Figure 2.34: The shrinkage (A) of scaffolds in X&Y and Z directions after dry at room
temperature and water adsorption (B) of scaffolds after incubating in deionized
water at 37°Ϲ.
Interestingly, it seems that most of the minerals only formed on the surface of the alginate
scaffolds, but few or no minerals appeared inside of the alginate strands. When the plotted
scaffold came in contac with Ca2+ solution, a fast reaction of Ca2+ and PO43- to form HAP
immediately took place at the surface of the alginate strands (as the interface between Ca2+
and PO43- rich areas). Because of the fast consuming of PO43- at the surface, PO43- from
inside (higher concentration) migrated to the surface (low concentration) continually. At
the same time, Ca2+ diffused from surface into the strands, but due to the inhibition by the
fast formed HAP shell and the consumption of calcium ions in the alginate crosslinking
reaction, the Ca2+ concentration decreased from surface to the centre of the strands.
Therefore, HAP was mainly formed at the surface. However, in the reports describing
alginate beads mineralized in situ, mineral particles formed on the surface as well as inside
of the beads [168-170]. Although the similar method of in situ mineralization was applied,
there are still some differences between the plotted alginate scaffolds and the prepared
alginate beads. The mineralized beads were using low concentration of alginate sol (less
than 2 wt %), but our plotted scaffolds used high concentration of alginate pastes (higher
than 15 wt %). The low concentration of alginate sols with very high water content
BA
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provided a faster circumstance for ions diffusion, furthermore, low concentration of
alginate sols consumed less Ca2+ for crosslinking reaction, compared to high concentration
of alginate pastes.
2.3.4.3 Mechanical tests
Compressive strength and modulus of the plotted scaffolds were tested in dry and wet
conditions. The data show that the compressive strength of core-shell scaffolds is higher
than that of pure alginate scaffolds (measured at 25% compressive strain) achieved in both
dry and wet state. The compressive strength of core-shell alginate/apatite scaffolds was
over 30 MPa at a compressive strain of 20% in dry state, and the strength increased
linearly with the strain. Young’s modulus of core-shell alginate/apatite scaffolds was
about 160 MPa in dry state, and therefore also higher than that of pure alginate ones.
However, the compressive strength and modulus decreased sharply in wet for pure
alginate and mixed alginate/HAP scaffolds, as well as for core-shell alginate/apatite
scaffolds (Figure 2.35).
Figure 2.35: Compressive strength of scaffolds in dry (A) and wet (immersed in SBF for 2 h at
37˚C) (B) states, compressive behaviour in dry state (C), and compressive modulus 
of scaffolds at 20% strain (D) (*p<0.05).
2. Calcium phosphate (CaP) and CaP/alginate scaffolds
66
The prepared core-shell scaffold was covered by a compact layer of apatite, which was the
main reason for the improved mechanical properties than pure alginate scaffold. The
compressive strength and Young’s modulus of all the plotted scaffolds were remarkably
lower in wet state compared to those in dry state. These three types of scaffolds were all
plotted with alginate as the bulk structures. After drying, all scaffolds suffered more than
30% of shrinkage which resulted in a significant increase of stiffness of the alginate
strands. However, after incubation in water, a significant amount of liquid was adsorbed
by the alginate strands and even the apatite layer was unable to prevent this. The water
adsorbed alginate strands were swollen and changed from stiff to soft which might be due
to the disruption of the strong hydrogen bonds in alginate.
2.3.4.4 Cell culture
Figure 2.36 and Figure 2.37 show SEM and cLSM images of hBMSC attached to and
grew on pure alginate, core-shell and mixed alginate/HAP scaffolds on 1 and 7 days of
culture. The cells attached and spread favourably on the core-shell scaffolds. In contrast,
cells on pure alginate scaffolds showed an altered morphology, and cells also had limited
attachment on directly mixed alginate/HAP scaffolds, especially on day 1. The
proliferations of hBMSC on scaffolds were evaluated by detecting the LDH activity and
are presented in Figure 2.38. The data show that more cells attached on the mineralized
and mixed scaffolds compared to the pure alginate one. Cell number was rather similar on
all three scaffold types after one week of culture and increased slowly up to day 14.
Between day 14 and 21 cell number raised further only in case of the pure alginate
scaffolds which might be due to the fact that the surface of the two others was already
completely covered with cells at day 14. The specific ALP activity was significantly
higher for cells cultivated on the mineralized 3D scaffolds, compared to both the pure
alginate and the mixed constructs. The maximum was found at day 14 which is a typical
time for osteogenically induced hBMSC.
There are sufficient evidences for showing the influence of surface properties of scaffolds
on cell attachment and shape [171-173], especially the surface composition and
morphology is known to have a strong effect. It has been demonstrated that alginate is not
a perfect material for cell attachment because it lacks specific interactions to integrins and
the negative charge might inhibit protein absorption due to electrostatic repulsion [174].
However, it can be improved by modifying the surface properties of alginate such as
grafting active peptides (RGD) [175]. The introduction of an apatite layer in this work
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changed the composition, as well as the morphology of the surface, which, therefore,
enhanced cell attachment. Both the nano-apatite and the rougher surface contributed to the
favourable attachment of hBMSC. Nano-apatite formation on the surface of scaffolds has
been performed extensively by incubation in SBF and the formed apatite layer has been
proved to lead to a significant improvement of cell attachment [176]. We also showed that
the formed apatite layer on alginate scaffolds by mineralization enhanced the hBMSC
attachment. The cell shape expressed on the mineralized scaffolds was much rounder
compared to those on pure alginate scaffolds. The cell morphology has strong influence on
cell functions and fate in hBMSC [177, 178]. It has been shown that hBMSC had smaller
and more rounded shape on a rougher surface of scaffold than on a smoother one, and the
cells with smaller spread area tended to better differentiate [179].
Figure 2.36: SEM images of hBMSC attached on scaffolds of pure alginate (A and D), alginate/
apatite core/shell (B, B´ and E) and mixed alginate/HAP scaffolds (C and F) on day
1 (A, B, B´ and C) and day 7 (D, E and F), respectively.
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Figure 2.37: cLSM pictures of hBMSC after seeding on alginate/apatite core/shell scaffolds (A)
and pure alginate scaffolds (B) for 24 h. Scale bar = 100 µm.
Figure 2.38: Proliferation (A) and specific ALP activity (B) of cells on plotted scaffolds over 21
days.
However, the formed apatite layers had not strong binding with alginate and tended to
detached from the alginate strands after incubation in cell culture medium for certain time.
One suggestion on overcoming this issue is to introduce some active groups on alginate to
enhance the interaction between apatite and the biopolymer. In the case of the mixed
alginate/HAP scaffolds, the strands were detached between the layers after soaking in
medium over 14 days because of the weak crosslinking due to the presence of the HAP
powder.
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2.3.4.5 Protein (BSA) delivery
Because of the mild preparation conditions (room temperature and no organic solvent
used), growth factors can be loaded into the pasty materials and plotted into scaffolds
directly. In this work, we selected BSA as model protein to study the protein delivery
ability from the plotted 3D scaffolds. Our data indicated that the BSA has a high loading
efficiency in mineralized core-shell scaffold (92.6±0.7%), which was significantly higher
than that in pure alginate (67.5±0.5%) and alginate/HAP (78.2±1.3%) scaffolds. BSA
showed a sustained release from the plotted scaffolds, especially from the mineralized
core-shell scaffold, where BSA was released over 25 days (Figure 2.39).
Figure 2.39: BSA loading efficiency (A) and release (B) from different types of plotted scaffolds
in SBF solution.
Our method for plotting alginate and core-shell scaffolds was performed under mild
conditions (room or physiological temperature and without using any organic solvent) and
in a highly efficient manner. It spent less than one hour from preparing plotting pastes to
finish the crosslinking and mineralization of the scaffold. Therefore, proteins (growth
factors) can be loaded into this system directly without denaturation. Through this way,
the protein loading efficiency was very high and the loading amount of protein can be
controlled.
2.4 Conclusion
In this chapter, several types of scaffolds with pre-defined structures (biphasic, mixed and
core-shell) and designed pore parameters based on alginate and CaP (CPC and HAP) were
fabricated by 3D plotting under mild conditions.
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The newly prepared ready-to-use CPC pastes allowed extended plotting and set under
physiological conditions. The pore size and porosity can be exactly controlled by the CAD
and the mechanical properties of plotted CPC scaffolds can be tailored by porosity. Cell
culture experiments indicated that the plotted ready-to-use CPC scaffolds supported cell
attachment, growth and differentiation.
The concentrated alginate pastes were also excellent for plotting and the resulting
scaffolds were showed higher mechanical stability than those prepared from low
concentrated alginate sols. The properties of alginate scaffolds were tailorable by
adjusting the PVA ratio in the prepared pastes. Alginate mixed with PVA contributed to a
scaffold with a micro-porous structure, low density, high water adsorption and then low
mechanical properties, compared to those prepared from pure alginate without mixing
with PVA.
In addition, the mechanical properties including compressive strength and toughness of
plotted CPC scaffolds were improved by simultaneous plotting of concentrated alginate
and CPC pastes, leading to biphasic structures. Such biphasic scaffold were also favorable
for cell attachment, as well as able to maintain controlled protein delivery. Furthermore, a
bipartite scaffold with separate layers for bone and cartilage was designed for
osteochondral tissue engineering and realized by plotting a CPC/alginate mixture for the
bony and pure alginate for the chondral part.
On the other hand, a novel alginate/apatite core-shell scaffold was prepared by using 3D
plotting and in situ mineralization. Such scaffold had an apparent core-shell structure with
a homogeneous apatite layer covering the alginate strands. The mechanical strength and
cell response were improved on this core-shell scaffold compared to the one of pure
alginate, as well as a high protein loading efficiency and sustained protein delivery could
be achieved.
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3. Hierarchical mesoporous bioglass (MBG) and
MBG/alginate scaffolds
3.1 Introduction
Silicon based mesoporous bioactive glass (MBG) has a highly ordered mesopore-channel
structure and hence an improved surface area and pore volume compared to non-
mesoporous biomaterials. These features make them having superior bioactivity as well as
excellent drug delivery ability [180-182]. There were plenty of reports on preparing MBG
nanospheres for drug delivery in vitro and in vivo, as well as scaffolds for hard tissue
engineering, such as scaffolds for bone regeneration. Previous studies have fabricated
MBG scaffolds by polyurethane templating. Although MBG scaffolds prepared by this
method have high porosity and strong bioactivity, the weak mechanical strength and
severe brittleness are main shortages because the sintering temperature is not allowed to
be high (normally not higher than 700°C), otherwise, the mesoporous structure would be
destroyed. Yun et al. [183] and García et al. [184] prepared hierarchical 3D porous MBG
scaffolds using a combination of sol–gel, double polymer template and rapid prototyping
techniques. In their study they mixed a MBG gel with methylcellulose, followed by
printing and finally sintering at 500–700 °C to remove the polymer templates and obtain
the MBG scaffolds. This method for preparing MBG scaffolds is inconvenient, because of
the need for methylcellulose and the additional sintering procedure. Although the MBG
scaffolds obtained had uniform pore structures, they were still brittle and not easy to
handle. In addition, the mechanical strength of these MBG scaffolds, although unknown,
is speculated to be low as the scaffolds were sintered at low temperature of only 500–
700°C, which normally is not enough for completely sintering ceramics particles together.
Furthermore, the incorporation of methylcellulose created some micropores with
diameters of several micrometers, which will further decrease the mechanical strength of
those MBG scaffolds.
In addition, MBG particles were also used as additive, introduced into polymer scaffolds
to improve the properties such as increase the mechanical strength and bioactivity and
drug delivery ability. Previous studies have shown that MBG particles have been
incorporated into polymers (e.g PCL, silk and poly(lactide-glycolide) (PLGA)) to improve
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their mechanical properties and apatite-formation ability [185-188]. Thus, it is expected
that the incorporation of MBG into 3D-plotted alginate scaffolds will efficiently solve the
existing problems of pure alginate scaffolds such as low mechanical strength, inadequate
bioactivity and burst drug delivery.
Herein, in this chapter, firstly, the fabrication of MBG/PVA scaffolds with MBG content
of 86% and 14% crosslinked PVA as binder by 3D plotting will be described. These
plotted MBG scaffolds have hierarchical structures of regular nanopores with a pore size
of 5 nm and uniform macro-pores with pore size from 200 µm to 2 mm (pre-defined by
CAD data set). The mechanical properties and bioactivity in vitro of these plotted
scaffolds were studied. Secondly, MBG as additive was incorporated into alginate
scaffolds. The potential application of the MBG/alginate scaffolds for bone tissue
engineering was explored by systematical investigation of their mechanical strength,
degradation, biological and drug-delivery properties.
3.2 Materials and methods
3.2.1 MBG/PVA scaffolds
3.2.1.1 Synthesis of MBG powder
MBG powder (molar ratio: Si/Ca/P = 80/15/5) was synthesized according to a published
procedure [182]. In a typical synthesis, 4.0 g of P123 (Mw=5800, Sigma-Aldrich,
Germany), 6.7 g of tetraethyl orthosilicate (TEOS, 98%, Sigma-Aldrich), 1.4 g of
Ca(NO3)2 · 4 H2O (Sigma-Aldrich), 0.73 g of triethyl phosphate (TEP, 99.8%, Sigma-
Aldrich) and 1.0 g of 0.5 M HCl were dissolved in 60 g of ethanol and stirred at room
temperature for 24 h. The resulting sol was introduced into a petri dish for an evaporation-
induced self-assembly process for 24 h, and then the dry gel was calcined at 700ºC for 5 h
to obtain MBG powder. The obtained MBG powders were ground and sieved through
300-meshes (300 micropores for each square inch), resulting in a particle size lower than
45 µm.
3.2.1.2 Preparation of plotting pastes and scaffolds
The plotting MBG/PVA pastes were prepared by mixing the prepared MBG powder with
15 wt-% aqueous PVA solution in a mass ratio of 1 to 1.1. Scaffolds with designed
3. Hierarchical mesoporous bioglass (MBG) and MBG/alginate scaffolds
73
morphology, pore structure, size and porosity were fabricated with the 3D plotter. The
dosing pressure was 5.2-5.9 bar and the plotting speed of the dispensing unit was 3 mm/s.
Cone-like plastic needles with inner diameter of 610 µm and 840 µm were adopted to
obtain different strand sizes. The obtained MBG scaffolds were dried at 40ºϹ overnight
and heated at 150ºϹ for 30 min for heat-crosslinking of PVA. The final dry weight of
MBG in the obtained scaffolds was 86%, and that of PVA was 14%. As a control, another
type of MBG scaffold was prepared by polyurethane foam template method according to
the literature [189] to compare their mechanical behavior. In brief, firstly, the
polyurethane sponges were immersed into the prepared MBG sol for 10 min, then they
were transferred to a Petri dish and squeezed out to remove the excess sol. After
evaporating the solution for 12 h at room temperature, the procedure was repeated six
times. Finally they were calcined at 700°Ϲ for 5 h to obtain the porous MBG scaffold.
3.2.1.3 Characterization of scaffolds and mechanical tests
The nano-channel structure of the MBG powder was observed by transmission electron
microscopy (TEM, FEI, Eindhoven, NL). The structures of the plotted scaffolds were
characterized with optical microscopy (Stemi 2000-C, Zeiss, Germany) and SEM.
The compressive strength and modulus of the obtained scaffolds (10×10×10 mm) were
tested using an Instron 5566 (Instron Wolpert, Darmstadt, Germany) at a crosshead speed
of 0.5 mm/min.
3.2.1.4 In vitro mineralization
MBG scaffolds were soaked in SBF with ion concentrations similar to those in human
blood plasma was prepared according to the method described by literature [142] at 37°C
for 1 and 3 d with a ratio of the solution volume to the scaffold mass of 200 mL/g. Apatite
mineralization of scaffolds was determined by SEM, EDS (Jeol JSM6510, Tokyo, Japan)
and FTIR (Spectrum 2000, Perkin Elmer, USA).
3.2.2 MBG/alginate composite scaffolds
3.2.2.1 Preparation of plotting pastes and scaffolds
The plotting pastes were prepared by mixing sodium alginate powder (Manugel®; ISP
Alginates Ltd. Waterfield, Tadworth, U.K.) and MBG powder (mass ratio of
MBG/alginate were 0 (0%), 1:10 (10%), 3:10 (30%) and 5:10 (50%), respectively) with
3. Hierarchical mesoporous bioglass (MBG) and MBG/alginate scaffolds
74
6% w/v aqueous polyvinyl alcohol (PVA, Mw~130,000; Sigma-Aldrich) solution. The
mass ratio of PVA solution/ (MBG+alginate) was 5:1, which means the alginate
concentration was 16.7 % w/w for 0% MBG/ alginate scaffolds. After stirring,
homogenous pastes were obtained and then transferred into 5 mL cartridges for plotting.
The plotting process was similar with the description given in chapter 2.2.1 in detail.
Pastes were extruded through a conic plastic nozzle with an inner diameter of 406 µm
(Globaco) at a constant plotting speed of 3 mm/s. A tear off speed of 15 mm/s was used to
disrupt the strands at the end. To optimize the pore structure, two types of scaffolds were
designed, named XY and XXYY pattern. For XY pattern, the scaffolds were plotted in the
x direction at the first layer and in the y direction at the second layer and then repeated
until the whole scaffold was finished. For XXYY pattern, the paste was deposited in the x
direction for two layers (the second layer on top of the first layer), and in the y direction
for the next two layers, then repeated until the whole scaffold was finished. After plotting,
the scaffolds were transferred into a 500 mM CaCl2 solution for crosslinking for 10 h, and
then washed with deionised water for three times and dried at room temperature.
3.2.2.2 Characterization of scaffolds
Pore size and morphology of the plotted scaffolds were characterized by optical
microscopy (Stemic 2000-C, Zeiss, Jena, Germany) and SEM (DSM 982-Gemini, Zeiss,
Oberkochen, Germany). The porosity was measured according to section 2.4.2. Shrinkage
of the scaffolds was calculated by measuring the length and height of the scaffolds before
and after drying. Five samples were tested.
3.2.2.3 Mechanical tests
The compressive strength and modulus of MBG/alginate composite scaffolds (8×8×8 mm3)
with XY or XXYY pattern were tested before and after immersion in SBF for 7, 14 and 28
days by using a mechanical testing machine (INSTRON 5566, Wolpert, Germany)
equipped with a 10 kN load cell. The test was performed by compressing wet scaffolds in
z-direction at a constant compressive rate of 0.4 mm/min and 30% of compressive
deformation was achieved for all scaffolds. Five samples were tested for each point.
3.2.2.4 Ions release and in vitro mineralization
The ionic release behaviour of MBG/alginate scaffolds was studied by soaking them in
SBF [142] at 37°C over a period of 42 days. At certain time points, pH value of the
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solution and release of Ca2+, SiO44- and PO43- ions were measured by pH meter and
inductively coupled plasma atomic emission spectroscopy (ICP-AES) (IRIS Intrepid II
XUV, Thermo Fisher, Germany) without updating solution, respectively. SEM and EDS
were used to characterize the apatite mineralization of the scaffolds.
3.2.2.5 Cell culture
A cell culture experiment was performed as described in detail in the previous part (2.2.9).
In brief, hBMSCs were cultivated in DMEM containing 10% fetal calf serum, 10 U/ml
penicillin and 100 µg/ml streptomycin (all from Biochrom, Berlin, Germany) at 37°C and
8% CO2. 5.5×105 cells in passage 5 within 400 µL of medium were seeded on scaffolds
with a size of 5×5×3 mm3. Osteogenic supplements were added to the medium starting
from day 1 after cell seeding. Medium was changed twice per week. Then the proliferation
and osteogenic differentiation of hBMSC on scaffolds were determined by measurement
of LDH activity and ALP activity, respectively. Cell morphologies on scaffolds were
observed by SEM.
3.2.2.6 Drug delivery
Dexamethasone (Dex) was selected as model drug to study drug release from the
scaffolds. Dex was loaded to MBG prior to preparation of MBG/alginate composite
pastes. Dex-loaded alginate scaffolds without MBG served as control. In detail, 5.4 mg of
Dex were dissolved in 10 mL of ethanol. Afterwards, 1 g MBG powder was added to the
Dex-ethanol solution and this mixture was stirred until the ethanol evaporated completely.
The Dex-loaded MBG powder was dried at 37°C and then used to prepare MBG/alginate
pastes for plotting of XXYY scaffolds as described in 2.2. For pure alginate scaffolds, Dex
was first dissolved in PVA solution and then mixed with alginate to construct Dex-loaded
alginate scaffolds. After plotting, the Dex-loaded scaffolds were crosslinked in 20 mL of 2
M aqueous CaCl2 solution for 30 min. Subsequently, the scaffolds were washed three
times with deionized water and the washing solutions were added to the remaining
crosslinking solution which was collected to detect the Dex loss by measurement of
absorbance at a wavelength of 240 nm.
Dex-loaded scaffolds were incubated in 4 mL SBF [142] at 37°C. At each time point, 2
mL of SBF was taken and centrifuged at 4000 rpm for 10 min. The concentration of Dex
was determined by measurement of absorbance at 240 nm. 2 mL of fresh SBF solution
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were added to the scaffolds for further incubation. Scaffolds without Dex served as blank
control. Three samples of each type of scaffold were tested.
3.3 Results and discussion
3.3.1 MBG/PVA scaffolds
3.3.1.1 Preparation of plotting pastes and scaffolds
The well-ordered mesopore channel structure of MBG with a pore size of 5 nm was shown
by TEM (Figure 3.1). The preparation of MBG is a layer by layer self-assembly process
by using sol-gel method. After selective burning the assembled polymer, the regular nano-
channel structures were achieved. These well-ordered mesopore channels not only
significantly increased the specific surface area of this bioglass but also introduced
additional functionality concerning of drug loading and delivery.
Figure 3.1: Transmission electron microscope (TEM) picture of MBG powder. (Provided by Dr.
Chengtie Wu)
Figure 3.2: Photograph showing the injectable MBG paste composed of MBG powder and
aqueous PVA solution (15 wt %) (A) and scaffolds fabricated by 3D plotting with
designed structure and size (B).
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The pastes prepared by mixing MBG powder with PVA solution was very efficient for
injection and extruding through fine needles, which can be used to fabricate 3D scaffolds
by plotting (Figure 3.2). After drying and crosslinking of PVA by improving its
crystallinity and controlling its dissolution, the scaffolds were stable and the ﬁnal dry 
scaffolds had weight content of 86% of MBG and 14% of PVA.
3.3.1.2 Characterization of scaffolds
Just as described already in chapter 2, the pore size and morphologies of scaffolds can be
designed and controlled by 3D plotting, pore size (from 100 micrometer to millimeters) as
well as the morphology (from cubic to hexahedral) of the fabricated MBG scaffolds bound
with PVA can be controlled over a wide range. The pore size of the MBG scaffolds varied
from 1307 ± 40, to 1001 ± 48, to 624 ± 40 µm and even smaller (200 µm) and the
pores were all open and interconnected. SEM image taken from the surface of MBG
scaffolds revealed that the MBG particles were bound together by PVA and formed a very
dense and rough surface (Figure 3.3). TEM image have already shown the regular
mesopores with size of 5 nm in the MBG particles; therefore, the prepared MBG 3D
scaffolds possessed hierarchical structures of controlled macro pores and nano-channels.
The predefined and open macropores will support cell migration and tissue growth, and
the well-ordered mesopores can be used for drug-loading.
Figure 3.3: Plotted MBG/PVA scaffolds with different pore size and shapes: 1307±40 µm (A),
1001±48 µm (B), to 624±40 µm (C)). MBG scaffolds with different pore
morphology (D and E). SEM image of the microstructure of pore walls (F).
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3.3.1.3 Mechanical properties
Mechanical properties are important factors and should be considered and studied in case
of scaffolds for bone tissue engineering and regeneration. Here, the compressive strength
and modulus of the plotted MBG/PVA scaffolds were examined. The data showed that the
compressive strength and modulus of the novel MBG/PVA scaffolds with a square pore
morphology and pore size of ca. 1000 µm are 16.10 ± 1.53 and 155.13 ± 14.89 MPa,
respectively. The corresponding porosity is 60.4% (calculated according to the pore and
pore wall sizes). The compressive profile showed that the compressive strength of
MBG/PVA scaffolds increased almost linearly with the deformation. After the maximum
value was achieved, the compressive strength did not decrease to zero immediately, but
still maintained at 10-13 MPa as the further deformation performed. As control, the
compressive strength of MBG scaffolds prepared by polyurethane templating was very
low (only 0.08 MPa), and the compressive profile increased irregularly with the
deformation. Photographs of scaffolds after compressing demonstrated that plotted
MBG/PVA scaffolds still maintained their bulk morphology after 35% deformation;
however, scaffolds prepared by polyurethane templating were crushed into powder (Figure
3.4). All these results indicated that the plotted MBG/PVA scaffolds significantly
increased the compressive strength (200 times) and improved the toughness compared to
MBG scaffolds prepared by polyurethane templating.
Figure 3.4: Typical strain-stress curves of a MBG scaffold prepared by 3D plotting (A) and
polyurethane templating (E). Photographs of plotted scaffold before (B) and after
(C) compression and polyurethane templating scaffold before (F) and after (G)
compression. SEM image of the surface of compressed plotted MBG scaffold (D)
(indicates the present PVA fibers sticking to the MBG particles (white arrows).
Scale bar for D = 2 µm.
E
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Furthermore, the plotted MBG scaffolds possessed signiﬁcantly higher mechanical 
strength than other inorganic scaffolds prepared by traditional methods, for example HAP
(lower than 0.29 MPa) [190], 45S5 Bioglass® (lower than 0.4 MPa) [191] and CaSiO3
scaffolds (lower than 0.4 MPa) [147]. In addition, compared to other polymer/ceramics
composite scaffolds, the MBG/PVA composite scaffolds prepared in this work also have
significantly stronger compressive strength. For example, Kalita et. al [192] fabricated
polypropylene/TCP composite scaffolds by fused deposition modeling, leading to similar
structures than those achieved by 3D plotting. The compressive strength of these scaffolds
with a porosity of 36% was 12.7 MPa (± 2 MPa), which is significantly lower than that of
our MBG/PVA composite scaffolds, even though they had a much higher porosity of 60%.
Two potential reasons were related with the significantly improved mechanical properties.
The first is the presence of PVA, which served as binder after heat-induced crosslinking
which binds MBG particles into a denser structure (visible in the SEM image Figure
3.4D). The second reason is the uniform and regular pore structure. Generally, a uniform
and continuous pore structure improves the mechanical strength [147, 148]. In this study,
since the porosity of the 3D plotted MBG scaffolds is controllable, it is believed that their
mechanical strength could be further improved by tailoring their porosity and pore
structure.
3.3.1.4 In vitro mineralization
Apatite formation on the surface of scaffolds by incubation in SBF plays an important role
in osteoblast attachment and growth and further for bone-forming ability in vivo. In this
work, plotted MBG/PVA scaffolds showed excellent apatite forming ability. After
soaking in SBF for 1 and 3 days, platelet-like apatite crystal with length of 200 nm and
width of 50 nm were deposited on the surface of plotted MBG/PVA scaffolds. EDS and
FTIR further characterized the apatite layer, which the peak of calcium and phosphate and
P-O bond were observed clearly in EDS and FTIR spectra, respectively (Figure 3.5).
MBG is a bioactive material, which has strong apatite mineralization ability in SBF. Our
novel MBG/PVA scaffolds also showed the strong apatite deposition ability, in which the
incorporation of a small PVA content had no significant influence on the apatite forming
ability.
3. Hierarchical mesoporous bioglass (MBG) and MBG/alginate scaffolds
80
Figure 3.5: SEM images of 3D-plotted MBG scaffolds after immergion in SBF for 1 d (A) and 3 d
(B, C). EDS (B, insert) analysis and FTIR spectrum (D) of MBG soaked in SBF for 3
d. (Performed by Dr. Chengtie Wu).
3.3.2 MBG/alginate composite scaffolds
3.3.2.1 Preparation of scaffolds
Our previous studies (section 2.3.2) have shown that the concentrated alginate pastes were
much more suitable for plotting and fabricating stable 3D scaffolds than low concentrated
alginate sols. In this chapter, we further showed that the prepared plotting pastes
consisting of highly concentrated alginate with incorporated MBG powder were all
applicable for extrusion through fine nozzles. The extruded alginate as well as
MBG/alginate strands kept their shape and position and stable 3D structures could be built
by plotting of multiple layers in air instead of CaCl2 solution (Figure 3.6). Incubation of
the scaffolds after completion of the plotting process in an aqueous CaCl2 solution led to
stable bonding of the strands.
Besides the selection of the most suitable alginate concentration, the optimal design is
quite important to construct an alginate-based scaffold with fully interconnected pore
structure. To our best knowledge, most of the conventional methods are unable to achieve
a structure-controllable scaffold. In this study, we found that the interconnectivity of
MBG/alginate scaffolds with XY pattern is not optimal, especially for the finer needles
(ID < 600 µm). To solve this problem, we applied a XXYY pattern and could demonstrate
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that the design has significantly improved the pore interconnectivity compared to XY
pattern. Digital pictures of MBG/alginate composite scaffolds with XY and XXYY
structure, respectively, at both wet and dry condition are presented in Figure 3.7. Scaffolds
with regular shape which matches the CAD model were fabricated successfully. The dried
scaffolds underwent shrinkage to a certain extent, but still maintained the regular cubic
shape as the wet ones. All scaffolds suffered from approximately 30% shrinkage in x and y
direction after drying, while shrinkage in z direction increased proportional to the MBG
content in the scaffolds.
Figure 3.6: Plotting of an alginate/MBG composite scaffold
Figure 3.7: CAD models (insert in the upper right corners) and plotted scaffolds (30%
MBG/alginate) with XY pattern (A) and XXYY pattern (B). Scaffolds are shown in
wet state after plotting, after crosslinking in 500 mM CaCl2 solution and in dry state,
respectively, from left to right.
BA
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3.3.2.2 Characterization of scaffolds
SEM analyses revealed the structure and morphology of XY and XXYY patterned
scaffolds with different MBG/alginate mass ratio. XY scaffolds had an open pore structure
according to the CAD model from top view, however, the pores were nearly closed from
side view (Figure 3.8). For XXYY scaffolds, the pores were completely open and
interconnected for all four types of scaffolds (Figure 3.9). High magnification SEM
images demonstrated an alteration in the surface structure of the scaffolds with increasing
amount of MBG: more MBG particles, closely embedded in the alginate strands, were
visible and the surfaces of the MBG/alginate composite scaffolds were much rougher than
that of the pure alginate scaffolds (Figure 3.10A-D). SEM images taken from cross
sections of the strands revealed that the pure alginate strands contain some micropores
inside; however, with increasing MBG content, the size of these micropores decreased and
the density of the strands increased (Figure 3.10E-H).
The porosity determined by liquid displacement was around 50% for XY and around 67%
for XXYY scaffolds (Table 3.1 and Table 3.2). No clear impact of the MBG content on
porosity was observed, probably because the mesopores of the MBG particles were not
accessible by this method.
Table 3.1.: The parameters of XY scaffolds after drying at room temperature
MBG/
alginate
X (shrinkage)
(%)
Y (shrinkage)
(%)
shrinkage
(Z) (%)
Pore size
(µm)
Pore wall
(µm)
Porosity
(%)
0 33.0±2.8 32.8±2.2 26.9±4.8 390±18 367±44 50.8±5.1
10% 31.5±1.0 32.3±1.1 31.1±3.6 415±30 341±37 51.7±7.6
30% 31.5±1.5 31.1±2.0 34.5±1.9 401±26 312±28 49.5±3.7
50% 33.7±1.3 33.4±1.7 39.1±1.3 344±24 338±17 50.2±7.1
Table 3.2.: The parameters of XXYY scaffolds after drying at room temperature
MBG/
alginate
X
shrinkage
(%)
Y
shrinkage
(%)
Z
shrinkage
(%)
Pore size
(X,Y) (µm)
Pore size
(Z) (µm)
Pore wall
(µm)
Porosity
(%)
0 29.1±1.0 28.3±1.4 32.7±2.2 348±39 370±26 403±26 67.7±5.1
10% 31.9±1.3 31.2±1.0 41.6±1.2 331±37 250±42 397±19 68.1±1.3
30% 31.8±0.9 31.3±0.6 39.7±1.0 345±23 191±22 416±18 67.2±3.9
50% 33.8±1.1 33.6±1.2 43.1±1.0 353±33 209±36 412±18 66.1±4.7
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Figure 3.8: SEM images of the XY scaffolds: top view (A, B, C and D) and side view (E, F, G,
and H). The MBG/alginate mass ratio was 0% (A, E), 10% (B, F), 30% (C, G) and 50%
(D, H), respectively.
Figure 3.9: SEM images of the XXYY scaffolds: top view (A, B, C and D) and side view (E, F, G,
and H). The MBG/alginate mass ratio was 0% (A, E), 10% (B, F), 30% (C, G) and 50%
(D, H), respectively.
Figure 3.10: High magnification SEM imcrographs showing the surface (A, B, C and D) and cross
section (E, F, G and H) of the strands of the scaffolds with MBG/alginate mass ratio
of 0% (A, E), 10% (B, F), 30% (C, G) and 50% (D, H), respectively.
E
A
E
B
F
C
G H
D
3. Hierarchical mesoporous bioglass (MBG) and MBG/alginate scaffolds
84
3.3.2.3 Mechanical tests
For bone tissue engineering applications, bioactive scaffolds with tailored mechanical
strength are needed [193]. In this study, Compressive strength tests were performed in wet
state after soaking the scaffolds in SBF for 2 h, 7, 14 and 28 days, respectively. The results
showed that the mechanical properties of MBG/alginate scaffolds were tailorable by
changing the amount of MBG and designing the scaffold morphology. The MBG content
modulated the mechanical strength of composite scaffolds: compressive strength and
modulus increased with raising amounts of MBG. Particularly, the 50% MBG/alginate
scaffolds had significantly higher compressive strength and modulus than that of pure
alginate scaffolds at each time point for both XY and XXYY patterns (Figure 3.11).
Figure 3.11: The compressive strength and modulus of the XY (A, B) and XXYY (C, D) scaffolds
after soaking in SBF for 2 h, 7, 14 and 28 days (the compressive strength was tested
with wet scaffolds); (n=5) (*p<0.05 for comparing 50% MBG/alginate scaffold with
0% MBG/alginate scaffold).
Mechanical properties decreased as the incubation time of scaffolds in SBF increased.
Moreover, the XY scaffolds had higher compressive strength and modulus than those with
XXYY pattern. The potential reason is that the MBG particles have a high surface area
and nano-pore volume [182], and the incorporation of MBG into alginate decreases the
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microporosity as shown in Figure 3.10. That in turn increases the stiffness of the alginate
strands. However, inclusion of 10% MBG to the XXYY patterned alginate scaffold led not
to a significant improvement of the mechanical properties compared to scaffolds without
MBG (0%). Furthermore, the XY patterned scaffolds have stronger mechanical properties
than XXYY patterned ones, which obviously is related to the open pores in Z direction in
XXYY scaffolds. The decrease of the compressive strength and modulus of XXYY
patterned scaffolds in association with incubation time in SBF can be explained by
degradation of the material and the swelling of the alginate strands.
3.3.2.4 Ion release
The pH value of SBF solutions, in which the four types of (XXYY) scaffolds were soaked,
was measured over 42 days (Figure 3.12A). The data revealed that the pH was stabilized
by MBG incorporated in the alginate scaffolds in a concentration-dependent manner. The
pH value of the SBF solution in which the scaffolds with the highest MBG content (50%)
were soaked dropped from 7.4 to 7.25 at day 1 but increased and was maintained at 7.4
with prolonged soaking time.
Figure 3.12: The pH value stability (A) and ions release (B, C and D) of scaffolds after soaking in
SBF solution. (Performed by Ms. Andrea Voß (IFW Dresden)).
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In contrast, the pH value of SBF solution, in which pure alginate scaffolds were soaked,
dropped to 7.2 and did not increase again during prolonged incubation. Calcium, silicate
and phosphate ion concentration in SBF soaked with scaffolds were detected by ICP over
42 days. The results showed that the amount of Ca2+ ion in SBF increased with time for all
types of scaffolds (Figure 3.12B), which originated in the ion exchange from the alginate
strands. Silicate release increased upon prolonged immersing time of MBG-containing
alginate composite scaffolds (Figure 3.12C). The concentrations of phosphate ions
decreased with time for all scaffolds (Figure 3.12D), especially at early time points, which
might be due to the precipitation of calcium phosphate phases because of the release of
Ca2+ ions from the calcium crosslinked alginate gels.
3.3.2.5 In vitro mineralization
Apatite mineralization of bioactive materials plays an important role in the formation,
growth, and maintenance of the tissue-biomaterials interface [187, 194]. In addition,
previous investigations have confirmed that a mineralized apatite layer has the capacity to
enhance osteoblastic activity [195-197], possibly by binding serum proteins and growth
factors to the substrate which then stimulate cell proliferation and activate cell
differentiation.
In this study, the data showed that most of the surface of pure alginate scaffolds was
smooth and without apatite deposition after soaking in SBF for 14 days (Figure 3.13A and
B). But apatite deposition might have occurred after incubation in SBF for more than 14
days such as for 28 days (see 2.3.2.3). However, needle-like apatite formed on the surface
of MBG/alginate composite scaffolds after soaking in SBF for 14 days, particularly for 30%
and 50% MBG-containing composite scaffolds (Figure 3.13D, F and H). EDS analysis did
not detect phosphorus on pure alginate scaffolds (Figure 3.13B insert). Strong phosphorus
signals appeared on 30% and 50% MBG-containing composite scaffolds (Figure 3.13F
and H insert). Incorporation of MBG significantly improved the apatite forming ability of
alginate scaffolds in SBF and cell culture medium [193]. The improved apatite-
mineralization ability of alginate scaffolds may benefit the hBMSC response to the
scaffolds.
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Figure 3.13: SEM images of the surface of scaffolds with MBG/alginate ratio of 0% (A, B), 10%
(C, D), 30% (E, F) and 50% (G, H) before (A, C, E and G) and after immersing in
SBF for 14 days (B, D, F and H). The insert figures show respective EDS analyses.
Scale bar = 1 µm.
3.3.2.6 Cell culture
To evaluate the suitability of the plotted MBG/alginate scaffolds as cell carrier for tissue
engineering applications, hBMSC were seeded and cultivated on the scaffolds and their
attachment, morphology, proliferation and osteogenic differentiation were investigated. As
observed by SEM after 1 and 7 days of culture, hBMSC attached and spread well on
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MBG/alginate composite scaffolds (Figure 3.14). They attached not only on the surface of
strands, but also spread over the gaps inbetween (Figure 3.14B and C). In contrast to the
composite materials, only few cells attached on pure alginate scaffolds (Figure 3.14A).
Figure 3.14: SEM images of hBMSC cultured on 0% (A, D), 10% (B, E and G), and 50% (C, F
and H) MBG/Alginate scaffolds, respectively, on day 1 (A, B, and C) and day 7 (D,
E, F, G and H). G and H are high magnifications of E and F, respectively.
After 7 days of culture, cells spread better on pure alginate compared to those on day 1
(Figure 3.14D). Adhesion of cells on the MBG containing scaffolds was also improved
(Figure 3.14E-H). Interestingly, apatite-like particles were formed on the surface of
MBG/alginate composite scaffolds as well as on the surface of cells, which was not
observed for pure alginate scaffolds.
Determination of the cell number at day 1 revealed that on MBG-containing composite
scaffolds a higher number of cells adhered. In contrast, after 7 days of culture no
difference between the four scaffold types was observed (Figure 3.15A). Determination of
specific ALP activity of osteogenically induced cells indicated that MBG supported
osteogenic differentiation of hBMSC. After 14 days of culture, ALP activity of hBMSC
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cultured on 30% and 50% MBG containing composite scaffolds was significantly higher
than that of pure alginate scaffolds (p<0.05) (Figure 3.15B).
Figure 3.15: MSC proliferation (A) and specific ALP activity (B) on alginate and MBG/alginate
composite scaffolds with 10%, 30% and 50% MBG content, respectively.
Concerning the improved cell attachment and higher specific ALP activity on
MBG/alginate scaffolds, compared to pure alginate ones, besides the improved apatite
mineralization [197], there are another two possible reasons which might contribute to the
improved cell response on the composite scaffolds. One is that the incorporation of MBG
leads to the release of bioactive silicate ion and stabilised the pH of the cell culture
medium [182, 194]. The other-one might be the increased surface roughness of the
MBG/alginate scaffolds, which leads to improved and selective adsorption of serum
proteins [198]. However, the fact that the proliferation of cells on MBG/alginate scaffolds
in the first week was not very high could be related to the strong calcium phosphate
precipitation, partly deposited on the attached cells, possibly influencing cell growth.
3.3.2.7 Drug delivery
The cumulative release profiles of Dex from pure alginate and MBG/alginate composite
scaffolds in SBF are shown in Figure 3.16. The initial burst release from the pure alginate
scaffolds in the first 24 h was over 70%, but less than 40% for MBG/alginate composite
scaffolds. After soaking in SBF for 120 h, Dex was completely released from pure
alginate scaffolds, whereas a sustained release appeared from MBG/alginate composite
scaffolds over 600 h. Release kinetics of Dex from the composite scaffolds was influenced
A B
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by the amount of MBG: the higher the MBG content, the lower the amount of released
Dex.
Figure 3.16: Drug (Dex) release profile from pure alginate scaffold and MBG/alginate
composite scaffolds in SBF over 25 days (A) and at the early stage (first 24 h) (B).
Controlled drug and growth factor release from scaffolds is of great importance for
regeneration medicine and tissue engineering [199]. In the present work, we have chosen
Dex as model drug because it is used for treatment of rheumatoid arthritis by virtue of its
anti-inflammatory function. Dex loaded into pure alginate scaffolds was released very fast
with a high initial burst at the early stage (0-120 h). In contrast, Dex loaded onto MBG-
particles was released much slower and more sustained from the composite scaffolds. One
potential explanation might be that the fast formation of an apatite layer on the surface of
the MBG/alginate scaffolds may slow down the Dex release as already described by Wu et
al. [199]. The release kinetics of Dex can be controlled by altering the MBG content in the
composite scaffolds, which is important for tissue engineering constructs with controllable
drug-delivery ability. Furthermore, the scaffold preparation and drug loading were
conducted under relatively mild conditions (room temperature and organic-free solvents).
Therefore, it is believed that our scaffolds are a useful platform to maintain drug/protein
activity for efficient delivery.
3.4 Conclusion
In this chapter, hierarchical scaffolds based on MBG/PVA and MBG/alginate with regular
nano-channels and designed macro-pores were fabricated by 3D plotting. Their potential
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application in bone tissue engineering were evaluated by studying their properties in vitro
including mechanical strength, apatite forming ability, hBMSC response and drug
delivery.
MBG/PVA scaffold with MBG as the main compoment and PVA as binder possess a high
compressive strength, about 200 times higher than that of scaffolds prepared by
polyurethane foam templating and strong apatite forming ability in SBF. This method also
can be used to fabricate other inorganic scaffolds with improved mechanical properties
such as HAP/PVA and CaSiO3/PVA scaffolds [44].
The incorporation of MBG powders (as additive) into the alginate scaffolds resulted in
further enhancement of the mechanical properties as well as in significantly increased
apatite mineralization and cytocompatibility. Moreover, the incorporation of MBG
decreased the initial burst and led to a more sustained release of Dex from the scaffolds in
a concentration-dependent manner. The plotted 3D MBG/alginate composite scaffolds
were suggested as potential candidates for application in bone tissue engineering and drug
delivery approaches.
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4. Gelatin/alginate/HAP composite scaffolds
4.1 Introduction
Gelatin is a natural material derived from collagen by hydrolysis and has almost identical
composition as that of collagen which is the major part of most ECM in animals [200].
However, compared to collagen with tis risk of antigenicity due to the xenogeneic origin,
gelatin has relatively low antigenicity, yet still contains some of the biological signals
which may promote cell adhesion, proliferation and differentiation such as the RGD
sequence [201-203]. The biological origin of collagen-derived gelatin makes this material
an attractive choice for tissue engineering. Therefore, gelatin has been prepared as
scaffolds by several methods for cartilage [204] and bone tissue engineering [70]. Freeze-
drying was the common used method to prepare gelatin scaffolds, although the pore
parameters were difficult to control. In addition, the group of Ma [70, 205] utilized a novel
freeze-drying method to fabricate gelatin scaffolds with nano fibers mimicking the ECM.
Such gelatin scaffolds were favorable for cells attachment and growth. However, the
mechanical properties of these nano fiber scaffolds are still insufficient for bone tissue
engineering. Another method for preparing gelatin scaffolds is electrospinning. As
mentioned previously, by electrospinning it is not easy to fabricate porous 3D scaffolds
with controllable macro-pores. In addition, the weak mechanical properties of such
scaffolds are problematic. Anyway, although gelatin is reported to be an excellent
substrate for cell attachment, proliferation, and di erentiation [206], the disadvantages of
using gelatin as sca old material in bone tissue engineering are its low biomechanical
sti ness and rapid biodegradation [207, 208]. Therefore, in this chapter mixtures of gelatin
and alginate with or without HAP were prepared and used to fabricate 3D scaffolds by 3D
plotting with the help of a heating system. The mechanical properties and cells response
on these scaffolds were evaluated and are presented here.
4.2 Materials and methods
4.2.1 Preparation of plotting pastes and scaffolds
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The plotting pastes consisting of mixtures of gelatin and alginate with or without HAP
were prepared by mixing alginate/HAP powder with an aqueous gelatin solution. For
preparing the gelatin/alginate mixture, first of all, a gelatin solution was made by
dissolving 16.7 wt. % gelatin (Sigma Aldrich) in deionized water (preheated to 90°Ϲ) 
under magnetic stirring (500 rpm and 90°Ϲ). After the gelatin powder was dissolved 
completely, the hot gelatin solution (still in sol state) was used to mix with alginate
powder in a mass ratio of 7 to 1 and then stirring until homogeneous pastes were formed
which were loaded into a cartridge for plotting. For preparing gelatin/HAP/alginate pastes,
a gelatin solution with HAP powder was generated by dissolving 11.8 wt.% gelatin in
deionized water (preheated to 90°Ϲ) and combine it with 9.5 wt.% HAP under magnetic 
stirring (500 rpm and 90°Ϲ). After gelatin dissolved completely, homogeneous mixture of 
gelatin solution and HAP was used in hot state to mix with alginate powder in a mass ratio
of 10.8 to 1. After a homogenous paste was formed it was loaded in cartridge for plotting.
The scaffolds were fabricated by 3D plotting with an electrical heating system, which has
a maximal temperature up to 120°Ϲ. The cartridge loaded with gelatin/alginate or 
gelatin/HAP/alginate mixture was equipped with in this heating system. The working
temperature was set in the range of 37°Ϲ to 80°Ϲ and adapted to the suitable dosing 
pressure and plotting speed. The technical details have been presented in section 2.2.1.
After scaffold fabrication, they were transferred into 1 M CaCl2 solution for crosslinking
alginate for 2 h, followed by washing of the scaffolds with deionized water three times
and drying at room temperature. Afterwards, the dry scaffolds were cross-linked with a 2
wt % solution of N-(3-dimethylaminopropyl) -N’-ethylcarbodiimide (EDC, Fluka,
Germany) and 0.25 wt % N-Hydroxysuccinimide (NHS) in 80% (vol %) ethanol for 12 h,
followed by thorough rinsing in deionized water, 1 wt % glycine solution, and once again
in deionized water. Scaffolds were dried at room temperature and stored for further use.
4.2.2 Microscopy and SEM analysis
The prepared scaffolds were characterized by light microscopy and SEM (Philips XL
30/ESEM, equipped with a field emission gun). For SEM, samples were coated with
carbon.
4.2.3 Mechanical tests
The compressive strength and modulus of plotted scaffolds with a size of 10×10×10 mm
were tested before (dry) and after immersion in SBF for 2 h (wet) by using a mechanical
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testing machine (INSTRON 5566, Wolpert, Germany) equipped with a 10 kN load cell.
The test was performed by compressing the scaffolds in z-direction at a constant rate of 1
mm/min and 30% of compressive deformation was achieved for all scaffolds. Five
samples were tested for each point.
4.2.4 Cell culture
The cell culture conditions have been described in detail in section 2.2.9. In brief,
scaffolds with size of 7.5×7.5×3.3 mm and regular and mismatch structures were
fabricated for cell culture experiment. After sterilization by gamma-radiation at 25 kGy
and pre-weting in cell culture medium for 24 h, 6×105 of hBMSC were seeded on each
scaffold, and then the scaffolds with cells were incubated in an incubator at 37°Ϲ and 8% 
CO2. Medium was changed twice per week. At each time point, three samples of each type
of scaffolds were taken out and washed with PBS twice and then frozen at -80°Ϲ for 
biochemical analysis.
Scaffolds were prepared also for SEM analysis by adding 3.7% formaldehyde to fix the
cells on the scaffolds for 30 min. Then the scaffolds were washed with distilled water, and
dehydrated using a gradation series of ethanol/distilled water solutions. Critical point
drying was performed with a CPD 030 apparatus (BAL-TEC AG, Liechtenstein). Dried
samples were coated with gold, and observed using a Philips XL 30/ESEM with FEG
(field emission gun) operated in SEM mode. Cells on scaffolds were also visualized by
MTT staining and observed by light microscopy (LEICA DFC295, Germany). The MTT
stock solution were prepared by dissolving 5 mg of MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) (Sigma, M5655) in 1 ml PBS. For staining the cells,
one part of the MTT stock solution and 9 parts of cell culture medium were mixed and
given to the scaffold (with cells) and incubated for 4 h. For preparing samples for cLSM
analysis, after washing with PBS (three times) and fixing cells on scaffolds with 4%
formaldehyde/PFA for 30 min at room temperature, and blocking the background with 3%
bovine serum albumin (Sigma-Aldrich) in PBS, cytoskeleton (actin) of the cells was
stained using AlexaFluor 488® phalloidin (Invitrogen, Carlsbad, CA) and nuclei were
stained with DAPI (dilute 1:1000 in PBS) (Invitrogen) and incubated in the dark for 1 h.
The confocal LSM characterization was performed with a cLSM (Leica TCS SP5,
Germany).
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4.3 Results and discussion
4.3.1 Preparation of scaffolds
Gelatin is a temperature sensitive material. The gelatin chains undergo a conformational
disorder-order transition and are able to form thermoreversible networks by associating
helices in junction zones, stabilized by hydrogen bonds, at sufficiently low temperature
[209]. Such as at room temperature, the prepared gelatin/HAP/alginate and
gelatin/alginate mixtures formed stable gels, which were unable to be extruded through
fine needles by even very high dosing pressure and big needle size (1.4 mm). Therefore, a
heating system is necessary for plotting gelatin and gelatin mixtures. Figure 4.1 shows the
plotting gelatin/HAP/alginate scaffold with the help of a heated cartridge and the plotted
scaffolds were stable and homogeneous. A study on the relationship between dosing
pressure and working temperature by plotting gelatin/HAP/alginate mixture was
performed and the data presented in Figure 4.2. It can be seen that the required dosing
pressure increased as the temperature decreased, however, when the temperature was
lower than 37°Ϲ, a very high pressure was required and even though, it became difficult to 
achieve homogeneous strands and stable scaffolds. Therefore, for plotting a homogeneous
gelatin/HAP/alginate or gelatin/alginate scaffold, a temperature higher than 37°Ϲ is
required.
Figure 4.1: Photographs of gelatin/HAP/alginate (39/31/30) scaffold being plotted (A) and
overview of the scaffold after plotting (B).
On the other hand, pure gelatin without addition of HAP power and alginate was
unsuitable for plotting, because pure gelatin is a liquid sol at high temperature, and a
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stable gel only at low temperature. At high temperature, liquid gelatin sol lacks sufficient
mechanical strength to support the porous 3D structure of a plotted scaffold, and it always
led to deformation of the pores and collapse of the structure, while at low temperature, the
gelatin gel was difficult to extrude through the plotting needle. After mixing gelatin
solution with alginate or alginate/HAP powder, the situation was improved. At suitable
temperature, the mixture was an injectable paste which could be extruded through a
plotting needle and also had sufficient mechanical strength to support the regular structure
of a plotted 3D scaffold.
Figure 4.2: The relationship between dosing pressure and working temperature by plotting gelatin/
HAP/alginate (39/31/30) mixture with different plotting speeds (ID needle = 0.61
mm).
4.3.2 Characterization of scaffolds
The plotted scaffolds were characterized by light microscopy and SEM. From the light
microscopical images (Figure 4.3), it can be seen that the pores of the scaffolds were
completely open in both regular and mismatch structure scaffolds. The appearance of
gelatin/HAP/alginate scaffold was white, while that of gelatin/alginate without HAP was
brown. The white appearance of gelatin/HAP/alginate scaffold was contributed by the
incorporated HAP particles. In addition, from top view, the pore size of the mismatch
structure scaffold was reduced, but still open and interconnected as in that with the regular
structure. SEM images (Figure 4.4) also showed the open and regular pores for
gelatin/alginate and gelatin/HAP/alginate scaffolds. High magnification indicated that the
surface of gelatin/alginate was very smooth and dense, as well as the cross-section.
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However, the surface of gelatin/HAP/alginate scaffold was course and also very dense and
abundant HAP particles were embedded in the strands.
Figure 4.3: Microscopical images of plotted gelatin/HAP/alginate (39/31/30) (A, C) and gelatin/
alginate (54/46) (B, D) scaffolds with structures: regular (A, B) and mismatch (C, D).
Figure 4.4: SEM images of plotted gelatin/alginate (54/46) (A, D, G), gelatin/HAP/alginate
(39/31/30) (B, E and H) and 50/20/30 (C, F and I) on the top view (A, B, C and I) and
high magnification on the surface (D, E and F) and cross-sections of strands (G and
H). C and I show the different structures (regular/mismatch).
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The plotted scaffolds either consisting of gelatin/alginate or gelatin/HAP/alginate suffered
certain shrinkage during drying due to the loss of water. Nearly 37% and 47% shrinkage
in X&Y and Z directions occurred for gelatin/alginate scaffolds (Figure 4.5). Although
great shrinkage happed, the plotted scaffolds still maintained the regular structures and
also the regular pore morphologies.
Figure 4.5: Shrinkage of the plotted gelatin/HAP/alginate scaffolds after drying at room
temperature.
4.3.3 Mechanical tests
The compressive strength and modulus were measured of dry and wet scaffolds at room
temperature. The obtained data is presented in Figure 4.6, and demonstrates that plotted
scaffolds crosslinked by EDC had high compressive strength and Young’s modulus in dry
state. The compressive strength and modulus of EDC crosslinked gelatin/HAP/alginate
(39/31/30) scaffolds were 77±13 MPa and 268±43 MPa, respectively, while the scaffolds
without EDC crosslinking had significant lower compressive strength (35±13MPa).
Furthermore, it can be seen from the stress-strain curves, that the compressive strength of
the scaffolds crosslinked with EDC increased with the compressive strain, while there was
no further increase after 18% strain for scaffolds without crosslinking. On the other hand,
the addition of HAP powder did not significantly improve the mechanical properties in dry
state. However, in wet state, the addition of HAP significantly increased the mechanical
properties, although the compressive strength and modulus of all plotted scaffolds
decreased sharply in wet state compared to those in the dry state. During drying, scaffolds
suffered around 40% shrinkage, which resulted in dense structures (SEM revealed the
dense and compact bulk structures of the scaffolds). Furthermore, the Ca2+ crosslinked
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alginate and EDC crosslinked gelatin formed interconnected networks, as well as the EDC
crosslinking between them [210], which all contributed to the very strong mechanical
properties of the gelatin/alginate scaffolds in dry state. However, gelatin and alginate are
both superior water adsorption materials, which are widely used as hydrogels. After
incubation gelatin/alginate scaffolds in SBF or other aqueous solutions, the scaffolds were
swollen due to the great water uptake, which then resulted in softening.
Figure 4.6: Compressive strength (A) and modulus (B) of plotted scaffolds with different mass
ratio of gelatin/HAP/alginate in dry and wet state (30% of compressive strain were
achieved, n=5, *p<0.05), as well as stress-strain curves of scaffolds in dry state (C).
On the other hand, comparison of the data achieved in this thesis to those from other
groups, it can be found that the mechanical properties of the plotted gelatin/alginate
scaffolds developed in this thesis were significantly higher than those of gelatin/alginate
scaffolds prepared by other groups by using conventional methods. For example, H. W.
Kim et. al [211] prepared mixed HAP/gelatin scaffolds by freeze-drying and the scaffolds
with 30% HAP and 84.6% porosity had the elastic modulus of 4.01±0.39 (dry) and
1.12±0.15 (wet) MPa. The modulus of our prepared scaffolds with a porosity of 70%
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(calculated according to the uniform pore and pore wall size) was 67 times of that in dry
state. The reason not only includes the lower porosity of our novel scaffolds, but more
importantly is the stronger and denser structure of the gelatin/HAP/alginate and
gelatin/alginate strands in dry state.
4.3.4 Cell culture
The morphology and distribution of the cells attached to the scaffolds were observed by
means of MTT stain (Figure F2 and F3), confocal LSM (Figure 4.7) and SEM (Figure 4.8
and 4.9).
Figure 4.7: Confocal LSM images of hBMSC on gelatin/HAP/alginate (39/31/30) (A, B) and
gelatin/ alginate (54/46) (C, D) scaffolds on day 1 (A, C) and day 21 (B, D). Scale bar
= 100 µm. (cytoskeleton (actin) of the cells was stained using AlexaFluor 488®
phalloidin (green) and nuclei were stained with DAPI (blue)).
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Figure 4.8: SEM images of hBMSC seeded on plotted scaffolds consisting of 39/31/30 (A, B) and
54/0/46 (C, D) gelatin/HAP/alginate on day1.
Figure 4.9: SEM images of hBMSC seeded on plotted scaffolds prepared of 39/31/30 (A, B) and
54/0/46 (C, D) gelatin/HAP/alginate on day 21.
C D
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From the obtained pictures, it can be seen that hBMSC attached and spread well on the
plotted gelatin/alginate scaffolds with or without incorporation of HAP on day 1, but the
cell density on gelatin/alginate scaffold was higher than on the gelatin/HAP/ alginate
scaffold. On day 21, cells covered the whole surface and even most of the pores of the
gelatin/alginate scaffolds, but less cells on the surface and the pores of gelatin/
HAP/alginate scaffolds (Figure 4.9 and Figure F3).
The incorporation of HAP in this system had no positive effect: the gelatin/alginate system
without HAP seems much better for cell attachment and growth. Gelatin, as mentioned,
which contains some of the biological signals which may promote cell adhesion,
proliferation and differentiation, is an excellent candidate for preparing scaffolds for tissue
engineering. In this study, we showed that a gelatin/alginate composite is also excellent
candidate for cell adhesion and proliferation, although the surface of the plotted scaffolds
was quite smooth.
4.4 Conclusion
In this chapter, gelatin was introduced into 3D scaffolds by plotting a mixture of gelatin
and alginate with or without HAP. The prepared high concentrated composite pastes were
suitable for 3D plotting under certain temperatures, and the plotted scaffolds were stable
after crosslinking with CaCl2 solution and EDC. The mechanical properties of the plotted
scaffolds were very high in dry state, although a sharp decrease occurred in wet due to the
great water adsorption. Human BMSCs attached and grew well on the plotted scaffolds.
Compared to alginate scaffolds (data presented in previous chapter), gelatin/alginate
scaffolds were much more favorable for hBMSC adhesion and proliferation.
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5.1 Introduction
Tissue engineering has been developed as a very active field in the past decades. However,
vascularization of tissue engineered constructs remains the key challenge for its clinical
application and is still not solved effectively. Several attempts have been made to realize
vascularization in vitro and in vivo [212,213], using cell-based and scaffold-based
strategies [213]. Cell-based strategies often try to fabricate vascular structures in vitro
through deposition of cells (such as spheroids consisting of endothelial and smooth muscle
cells) layer by layer [214-216]. However, utilization of this method is still limited by poor
mechanical properties and high complexity. Scaffold-based strategies, which focus on
fabricating 3D porous scaffolds or hydrogels including an artificial vascular-like structure
and controlled release of growth factors, are promising for promoting vascularization but
must be combined with cellular approaches to be successful [217,218]. Various techniques
have been developed for producing such scaffolds and constructs including soft
lithography [219], stereolithography [220] and direct fugitive ink writing [221-223].
Furthermore, fabricating 3D porous scaffolds with controllable macro-pores and open
channel structures under mild conditions as a prerequisite for combination with live cells
or biological factors is still a challenge for these techniques.
3D bioplotting, as one of the rapid prototyping techniques suitable for scaffold fabrication,
is an attractive method for creating 3D porous constructs with defined properties for tissue
engineering as described in previous parts. 3D scaffolds consisting of solid strands have
been fabricated successfully by this method using a variety of polymers as well as
ceramics or composites, which was described in the previous chapters. In addition, Moroni
and co-workers [224] fabricated porous 3D scaffolds with hollow fibers by extruding a
mixture of two polymers with different viscosity. The hollow strands were formed by
selectively dissolving the inner polymer of the core-shell structures. However, this method
is limited by the requirement of using organic solvents, which prevents plotting with cells
or sensitive substances like growth factors.
Herein, we demonstrate a very simple and direct method to create 3D porous scaffolds
with regular macro-pores and a network of adjustable hollow fibers based on concentrated
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alginate/PVA pastes as artificial vasculature-like system by 3D bioplotting under mild
conditions. This hollow fiber scaffold was characterized by microscopy and SEM. The
mechanical properties of the hollow fiber scaffolds were tested, including the ultimate
strength of the hollow fiber and compressive strength and Young’s modulus of the 3D
scaffold. Human BMSC were seeded on the scaffolds and cLSM, SEM and MTT staining
demonstrated cell attachment and survival on these scaffolds.
5.2 Materials and methods
5.2.1 Preparing pastes and core/shell needles
The plotting pastes were prepared by mixing sodium alginate powder (Manugel®; ISP
Alginates Ltd. Waterfield) with PVA (Sigma-Aldrich, Mw~130,000) as a 6%w/w aqueous
solution in a mass ratio of 1 to 5, and stirring until homogeneous pastes were achieved
which then were transferred into plotting cartridges (Globaco GmbH). For preparing
hollow fibers and hollow fiber scaffolds, shell/core needles were assembled with a very
simple method. A stainless steel needle with a bent cannula in 90° angle (Techcon systems
GmbH) with smaller diameter were inserted into a conic plastic needle with bigger
diameter in a manner that the tips of the two nozzles were on the same level and not
touched each other (Figure 5.1). Several sizes of shell/core needles were made and used in
this work, including those with a size of (outer/inner diameter; µm): 400/100, 610/150,
610/200, 840/200, 840/250 and 1190/450.
5.2.2 Preparing hollow fibers and 3D hollow fiber scaffolds
The hollow fibers and 3D hollow fiber scaffolds were fabricated by extruding the prepared
alginate/PVA pastes through the shell/core needles on a receiver (plastic film or cell
culture dish) by 3D plotting. The present configuration of the system allows the
manufacturing of three different pastes in one scaffold. 3D scaffold, with geometries
created by CAD, were produced by 3D plotting through layer by layer deposition under
the control of CAM. The plotting speed was 3 mm/s and dosing air pressure ranged from
600 kPa to 800 kPa according to the size of the shell/core needles. After the 3D hollow
fiber scaffolds were composed, they were transferred into 500 mM CaCl2 solution for
crosslinking of alginate for 3-5 h. Optionally, vacuum was applied to force the CaCl2
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solution to penetrate the lumen of the hollow fibers. Afterwards, the scaffolds were
washed with deionized water three times and dried at air and room temperature.
5.2.3 Characterization of fibers and scaffolds
The single hollow fibers were characterized by reflected-light microscopy (Axiolab A,
Carl Zeiss, Germany) and the diameter of the fibers were measured with the help of a
software (Axiovision 4.7.2, Carl Zeiss Microimaging GmbH, Germany). For investigating
the patency of the single hollow fibers a red food coloring (Wusitta, Germany) was used.
The 3D hollow fiber scaffolds were characterized by optical (Stemi 2000-C, Zeiss,
Germany) and scanning electron microscopy (Philips XL 30/ESEM, equipped with a field
emission gun). For SEM analysis, dried scaffolds were cut with a razor blade and coated
with gold.
5.2.4 Mechanical tests
Ultimate strength of hollow fibers and compressive strength and modulus of 3D hollow
fiber scaffolds (7×7×7 mm) were tested on dried and wet samples (immersed in SBF for 2
hours at 37˚C) by a mechanical testing machine (INSTRON 5566, equipped with a 10 kN 
load cell; Wolpert, Germany). The tests were performed by compressing five samples of
each type at a constant compression rate of 1 mm/min.
5.2.5 Cell culture
Human BMSC in passage 5 were seeded on the plotted hollow fiber scaffolds (6×105 cells
on each scaffold) and the resulting cell-matrix-constructs were cultured in DMEM
containing 9% fetal calf serum, 10 U/mL penicillin and 100 µg/mL streptomycin (all
components purchased from Biochrom, Germany) for 14 days at 37° Ϲ and 8% CO2. For
MTT staining, the cell culture medium was supplemented with 1.2 mM 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetra-zolium bromide (Sigma-Aldrich, Germany) and
the cell-seeded scaffolds were further incubated for 4 h followed by microscopic analysis
(LEICA DFC295, Germany). For preparing SEM samples, scaffolds seeded with cells
were washed with PBS twice and fixed with 3.7% formaldehyde in 100 mM CaCl2
solution for 30 min, washed with distilled water, and dehydrated using a gradation series
of ethanol/distilled water mixtures. Critical point drying was performed with a CPD 030
apparatus (BAL-TEC AG, Liechtenstein). Dried samples were coated with gold and
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observed using a Philips XL 30/ESEM, equipped with a field emission gun and operated
in SEM mode. For preparing samples for confocal LSM analysis, scaffolds seeded with
cells were washed with PBS three times and fixed with 4% formaldehyde/PFA for 30 min
at room temperature, then washed the samples with PBS again for three times. The
nonspecific fluorescence (background) was blocked with 3% BSA in PBS, and then
washed with PBS again for three times. Cytoskeleton (actin) of the cells was stained
using AlexaFluor 488® phalloidin (Invitrogen, Carlsbad, CA) and nuclei were stained
using DAPI (dilute 1:1000 in PBS) (Invitrogen, Cat.# D3571) and incubated in dark for
1h. The confocal LSM characterization was performed by cLSM (Leica TCS SP5,
Germany).
5.3 Results and discussion
5.3.1 Preparation and characterization of hollow fibers
With the shell/core needles (Figure 5.1) and the concentrated alginate/PVA pastes, meter-
long hollow fibers were easy to prepare even without the requirement of a 3D plotting
device. The extruded hollow alginate/PVA fibers of different diameters showed uniform
wall thicknesses and we could demonstrate that different sizes of the hollow channels
could be prepared. Light microscopic pictures of the end of the hollow fiber showed that
they were completely open (Figure 5.2).
Figure 5.1: Microscopy pictures show the tips of the constructed core/shell needles with sizes of
400/100 (A), 610/200 (B) and 840/250 (C) µm.
The openness and tightness of the hollow alginate fibers was further confirmed by a dye
injection test (Figure 5.3). A liquid red dye was running through the whole hollow strand
from one end of the fiber under a given light pressure, and little drops leaked from the
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other end. After 90 min of incubation in CaCl2 solution, the red dye was almost vanished
from the tube. These results indicated that the hollow fibers were open at both ends and
continuous. Furthermore, the data suggest that the hollow alginate fibers have a good
permeability and transport capability, which is important concerning the function as
artificial blood vessels to transport and distribute oxygen and nutrients. The diameters of
the hollow fibers were controlled by adjusting the diameters of shell/core needles (Figure
5.4A). The size of the lumen was mainly related with the core needle size. However, the
outer diameter of the hollow fiber was depending on the shell needle size, as well as on
the plotting speed and dosing pressure (Figure 5.4B). The plotting speed had to be
adjusted to the extrusion speed of the materials to obtain uniform and regular fibers and
scaffolds.
Figure 5.2: Microscopic pictures of plotted hollow fibers with different sizes of core-shell
needles: 400/100 (A, E and I); 610/200 (B, F and J); 840/250 (C, G and K) and
1190/450 µm (D, H and L); in the middle (A- D) and end (E-L) of fibers.
Our method for preparing hollow alginate fibers is much simpler compared to that using a
special microfluidic chip demonstrated in the literature [225]. With this chip, hollow
alginate fibers with meter length were achievable, too. However, due to the low alginate
concentration (2% w/w) used with this technique they are fragile and difficult to handle
400/100 610/200 840/250 1190/450
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and tend to deform during drying. Furthermore, with this method it is not possible to
create uniform 3D scaffolds. Our hollow fibers prepared of concentrated alginate pastes
were stable concerning handling after crosslinking in CaCl2 solution and underwent little
deformation during drying, although about 30% shrinkage occurred. The ultimate strength
of these hollow fibers was significantly higher than that of fibers prepared from low
concentrated alginate pastes with the microfluidic chip (Figure 5.5). Furthermore, our
method is very simple and suitable to fabricate 3D scaffolds with controllable inner and
outer morphology by means of 3D plotting.
Figure 5.3: Photographs of the hollow alginate fiber before (A) and after (B) injection of a liquid
red dye through one end of the fiber and the fiber in CaCl2 solution after 90 min (C).
Figure 5.4: Relationship of fiber sizes with different size of core-shell needles (A) and the
relationship of fibre size with plotting speed and dosing pressure with core-shell
needles of 400/100 µm (B).
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Figure 5.5: Ultimate strength of hollow fibers prepared with different size of core-shell needles.
5.3.2 Preparation and characterization of 3D hollow fiber scaffolds
Combining the shell/core needles with a 3D plotting system, 3D porous scaffolds with
defined structure and orientation of hollow channels were easy to be obtained by a one-
step process. The receiver of the plotted scaffolds could be a cell culture dish (Figure
5.6A) or plastic film (Figure 5.6B). Figure 5.6C shows the overview of a plotted
alginate/PVA scaffold consisting of 16 layers of hollow strands. The scaffold had a
regular shape and open channels at the ends of the fibers.
Figure 5.6: Photographs of scaffolds were plotting with core-shell nozzles of 610/150 (A) on cell
culture dish and 840/250 µm on plastic film (B) and the plotted scaffold consisting of
16 layers (C).
After plotting, the scaffolds were transferred to an aqueous 500 mM CaCl2 solution for
crosslinking of alginate and dissolving of PVA. Interestingly, the hollow fiber scaffold
was floating on top of the CaCl2 solution before vacuum was applied and sank to the
A B C
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bottom after evacuation (Figure 5.7). Before vacuum was drawn, the hollow fibers were
air-filled and the scaffold therefore lighter than the CaCl2 solution, thus the scaffold
floated on top of the liquid. After vacuum application, the air was removed from the
hollow channels and the CaCl2 solution went in, which make the scaffold heavier than the
solution and the scaffold sunk to the bottom of the beaker. This indicated that the hollow
strands of the scaffold were completely open, continuous and empty. However, the
scaffolds consisting of non-hollow alginate/PVA strands, produced as control, always
stayed at the bottom of the CaCl2 solution. Light microscopy pictures (Figure 5.8) and
SEM (Figure 5.9) further confirmed that the regular hollow fiber scaffolds not only had
interconnected macropores (the pores between the strands), but also an open hollow
channel structure. High magnification SEM micrographs revealed that the surface of the
hollow strands was smooth and dense, whereas the tube walls were porous with a pore
size of ca. 6 µm. These micropores were produced by the dissolution of PVA in CaCl2
solution and phase separation of the calcium alginate gel during drying.
Figure 5.7: Photographs of plotted hollow and non-hollow scaffold soaked in 500 mM CaCl2
solution before (A) and after (B) putting in reduced pressure situation.
The plotted 3D constructs consisting of hollow strands are suggested to be used as
scaffolds for tissue engineering, either for providing a matrix for in vitro vascularisation or
the generation of complex tissues like liver or kidney. The macropores of the scaffolds
could support e. g. bone tissue formation, while simultaneously the hollow strands can be
used to create blood vessel-like channels.
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Figure 5.8: Light microscopical images of hollow fiber scaffolds plotted with core-shell needles of
size 610/150 (A, E); 610/200 (B, F); 840/250 (C, G); 840/330 µm (D, H). Top view
(A-D) and cross sections (E-H). Scale bar = 500 µm.
Figure 5.9: SEM images of hollow fiber scaffolds plotted with core-shell needles of 840/250 (A
and D) and 610/200 µm (B and E) on cross section and high magnification on the
surface (C) and inside (F) of the hollow fibers. Scale bar = 500 µm (A, B), 100 µm
(D, E) and 10 µm (C, F).
5.3.3 Mechanical tests
The plotted porous 3D scaffolds with hollow channels were suggested to be used as tissue
implants, such as for bone tissue engineering. The macropores of the 3D structure support
bone tissue formation, simultaneously, the hollow channels were suggested as guiding
structure for vascularisation. The mechanical properties of the material were considered as
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an important factor, especially for application as bone tissue implants. Therefore, the
compressive strength and Young’s modulus of the alginate hollow fiber scaffolds were
evaluated in dry and wet state.
The obtained data (Figure 5.10) revealed that the porous alginate scaffolds consisting of
hollow strands had a significantly higher compressive strength and modulus than those
prepared by conventional methods and with low concentration of alginate [75, 160-162].
The reasons have been explained in section 2.3.2.4, including the uniform structure and
regular orientation of the strands in plotted scaffolds and the utilization of high
concentrated alginate pastes, which makes the alginate fibers suffer no critical deformation
during plotting and drying. The mechanical properties of the hollow fiber alginate
scaffolds were adaptable by the porosity of the scaffolds and the tube wall thickness of the
hollow strands, which could be controlled by the size of shell/core needles and the plotting
parameters (plotting speed and dosing pressure).
Figure 5.10: Compressive strength (A, B) and Young’s modulus (C, D) of 3D hollow fiber
scaffolds in dry (A, C) and wet (B, D) state (n=5).
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5.3.4 Cell culture
Human BMSC were seeded and cultivated on the plotted hollow fiber scaffolds to
evaluate their cytocompatibility. After 1, 7 and 14 days of culture, viable cells were
visualized by confocal LSM, SEM and MTT staining, respectively. Microscopic images
(shown in Figure 5.11, Figure 5.12 and Figure 5.13) illustrate good attachment and
spreading of the hBMSC – not only on the outer surface of the hollow fibers, but also to
the inner walls of the tubes. Furthermore, cells can attach around the hollow strands
forming a tube structure. These observations indicate that the plotted hollow fiber
scaffolds based on concentrated alginate/PVA pastes support cell adhesion and viability.
Figure 5.11: Confocal LSM picture of hBMSC seeded on the hollow fiber scaffolds on day 1.
Scale bar = 100 µm.
Figure 5.12: SEM images of hBMSC seeded on the hollow fiber scaffolds on the surface (A) and
hollow channel (B) after 7 days of culture. Arrow in B indicated the cells inside in
the hollow fiber.
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Figure 5.13: MTT stain images of hBMSC seeded on the hollow fiber scaffolds on the surface (A)
and hollow channel (B) 14 days of culture.
5.4 Conclusion
In conclusion, in this chapter a very simple and gentle method to create hollow fibers and
scaffolds with designed macro-pores and controllable hollow channels based on
concentrated alginate/PVA pastes and adapted core/shell needles was described. Hollow
fibers with outer diameters ranging from 200 µm up to more than one millimeter were
achievable. The produced hollow fibers and 3D scaffolds possess significant stronger
mechanical strength and modulus compared to that of low concentrated alginate hollow
fiber and scaffolds made thereof and support hBMSC attachment and spreading. This
novel method has the potential to support the design of pre-vascular structures for tissue
engineering and regenerative therapies and the creation of complex tissues models.
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6.1 Summary
In this thesis, several types of scaffolds with pre-defined inner and outer morphology
fabricated by 3D multi-channel plotting and suitable for bone tissue engineering and
regeneration were developed and described. The materials selected for preparing the
scaffolds included polymers (alginate, PVA and gelatin) and ceramics (CPC, HAP and
MBG) either with sole-material (pure CPC, pure alginate), or mixed ceramic/polymer
composite (CaP/alginate, HAP/alginate, MBG/PVA, MBG/alginate and HAP/alginate/
gelatin). The structures included biphasic and bipartite (CPC/alginate), core/shell
(alginate/apatite) and hollow fiber (alginate/PVA). The necessary functions including
suitable mechanical properties, favorable cells response, controlled drug and protein
delivery and options for in vitro vascularization were achieved.
In chapter 2, scaffolds fabricated by 3D plotting based on CPC and alginate were
described. First of all, pure CPC and alginate scaffolds were fabricated by plotting a newly
developed ready-to-use CPC pastes and concentrated alginate/PVA pastes, respectively.
The novel CPC pastes (derived by mixing CPC precursor powder with biocompatible oil
instead of aqueous) allowed extended plotting, as well the developed concentrated alginate
pastes were mechanical stable and excellent for 3D plotting. Based on these two materials
and the multi-channel plotter, a novel biphasic organic/inorganic scaffold was then
fabricated by simultaneously plotting CPC and concentrated alginate pastes. Such biphasic
scaffold containing both organic and inorganic networks had improved mechanical
properties (such as mechanical strength and toughness) compared to pure CPC and
alginate scaffolds (in wet state). Cells (hBMSC) also attached well on this biphasic
scaffold. In addition, proteins (BSA) could be loaded into these materials which then were
used to prepare scaffolds under mild conditions. The incorporated protein released much
faster from alginate strands than from CPC strands, which suggested that protein delivery
can be designed in an amount-controlled manner by altering the loading amount of protein
in CPC and alginate phases. Furthermore, a novel bipartite scaffold containing alginate
and CPC/alginate biphasic layers for repairing osteochondral defects was also fabricated
successfully by 3D plotting. Thirdly, a novel core/shell scaffold with apatite as shell layer
and alginate as core was created by combining 3D plotting and in situ mineralization. The
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core/shell scaffolds had improved mechanical strength and cell attachment, as well as
sustained protein delivery ability compared to pure alginate scaffolds.
In chapter 3, a Si-Ca-P bioglass with regular nano-channels (MBG) was introduced into
3D scaffolds for bone tissue engineering. MBG as the solid part and PVA solution as the
liquid part were mixed into homogeneous pastes, then 3D porous scaffolds with designed
size and morphology were plotted. After crosslinking PVA as binder of MBG particles,
the plotted MBG scaffolds had stronger mechanical properties. The compressive strength
of such MBG/PVA scaffolds was 16 MPa and therefore 200 times that of porous MBG
scaffolds prepared by polyurethane templating. In addition, the plotted MBG/PVA
scaffold showed favorable apatite deposition after incubating in SBF. In the second part,
MBG particles served as additive were introduced into alginate scaffolds. The
incorporation of MBG improved the mechanical strength, apatite formation in SBF and
cell attachment ability. Moreover, the incorporation of MBG decreased the initial burst
and led to a more sustained release of Dexamethasone (as a model drug) from the
scaffolds in a concentration-dependent manner.
In chapter 4, gelatin, a favorable material for cell attachment and cultivation, was
introduced to fabricate scaffolds by 3D plotting. The plotting pastes were prepared by
mixing a selected mass ratio of gelatin and alginate with or without addition of HAP, and
the prepared pastes were suitable for plotting under certain temperature. After
crosslinking, the plotted scaffolds had regular macro-pores but also very dense strand
structure, which contributed to strong mechanical properties (including compressive
strength and Young’s modulus) in dry state. Human BMSC attached and grew very well
on these gelatin/alginate scaffolds.
In chapter 5, a novel type of scaffold with hollow strands was fabricated based on the
concentrated alginate pastes and constructed core/shell needles by 3D plotting under mild
conditions. The produced hollow fibers and 3D scaffolds possessed mechanical strength
and modulus comparable to that of normal, filled strands and scaffolds made thereof and
supported hBMSC attachment and spreading. The hollow fibers and hollow fiber scaffolds
were introduced as matrix for guiding vascularization in vitro.
In conclusion, this thesis describes several types of scaffolds fabricated by 3D plotting
based on polymers and ceramics with predesigned structures and targeted functions. The
scaffolds and methods for their fabrication provide fundamental knowledge and a potential
platform for bone and other fields of tissue engineering and regenerative medicine,
including new perspective for creating artificial vascular networks in TE constructs.
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6.2 Future work and outlook
Fabricating ideal scaffold remains one of the main tasks in the field of tissue engineering
and regenerative medicine. Based on the 3D plotting technique and the plotted scaffolds
with designed structures and functions, developed in this thesis, the following
recommendations for the continuation:
1. Fabrication of multi-functional scaffolds, such as dual release systems. Several types
of drugs and/or growth factors released from one scaffold in an individually controlled
manner.
2. Construction of cell-loaded hollow-fiber scaffolds for vascularization by plotting
multiple types of cells on/in the scaffolds directly, with the assistance of growth factor
delivery.
3. Fabrication of complex cell-matrix constructs by plotting different cell types in a
designed manner by combining plotting of cells-loaded spheres and strands.
Based on this work, a dual release system can be realized in plotted scaffolds. For
example, MBG with nanopores can be used as carries for small molecular weight drugs,
whereas a polymer matrix (such as alginate pastes) can be applied as the carries for
proteins and growth factors. A layer of apatite formed on the surface of the strands can
lead to a sustain release of proteins, as well as drugs from the nanopores of MBG. On the
other hand, several types of nano/micro-particles as drug and growth factor reservoir can
be loaded into the plotted scaffolds to achieve a multi-release system. Furthermore,
because multi-channel plotting can be used with different materials simultaneously,
several types of growth factors can be loaded into different materials and plotted in a
designed spatial manner, would lead to multiple delivery system.
Secondly, as described in chapter 5, the direct creation of hollow alginate fiber scaffolds
was performed under mild conditions (at room temperature and without utilization of any
organic solvent) and in a highly effective manner (plotting a small scaffold only needs a
few minutes). This makes it possible to include different types of living cells and/or
growth factors in the plotting process. For creating vascular structures, endothelial cells,
suspended in cell culture medium (or a liquid hydrogel), are loaded in a cartridge and then
plotted through the core nozzle into the hollow channels (Figure 6.1). Simultaneously,
smooth muscle cells, suspended in the alginate/PVA pastes, are loaded in another
cartridge and plotted through the shell nozzle into the shell of the hollow fibers. Then the
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double cell-loaded hollow fiber scaffold will be transferred to Ca2+-enriched cell culture
medium for crosslinking of alginate. Afterwards, hBMSC or osteoblasts are seeded
conventionally on the already cell-loaded scaffold. For enhancing attachment of cells,
alginate can be modified by bioactive agents (such as RGD peptides) or combined with
gelatin before plotting the scaffolds. Other studies revealed that RGD-modified alginate is
able to improve proliferation and adhesion of cardiac myoblasts and endothelial cell, as
well as angiogenic response [60, 226].
Figure 6.1: Schematic of building bone tissue with rich pre-vascularization in vitro: Endothelial
cells, suspended in cell culture medium, are loaded in a cartridge and then plotted
through the core needle into the lumen of the hollow fibers. Simultaneously, smooth
muscle cells, suspended in alginate/PVA pastes, are loaded in another cartridge and
plotted through the shell needle into the walls of the hollow strands. Then the cell-
loaded hollow fiber scaffold is transferred to Ca2+-enriched cell culture medium for
crosslinking the alginate. Afterwards, hMSC are seeded on the cell-loaded scaffolds
and stimulated to differentiate into osteoblasts. A dynamic co-culture technique
(bioreactor) is required to further cultivate the constructs: Two different types of cell
culture media are pumped circularly through the scaffolds. Medium favorable for
MSC and their osteogenic differentiation is pumped through the macropores of the
scaffold whereas the hollow tubes are perfused with medium for endothelial cells.
The next step would be to transplant the in vitro product into animal model for in vivo
vascularization (A). First realized core/shell scaffolds by 3D plotting of different
materials with core/shell needles (B) (Images B by Ashwini Rahul Akkineni).
Bioreactor
A
B
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This triple-culture system with three different cell types should lead to an artificial bone
tissue with rich pre-vascularisation, which might facilitate integration in the host tissue
after implantation in vivo (Figure 6.1A). The possibility to plot complex 3D hollow fibers
under physiological conditions – and to include different cell types with a defined
arrangement and spatial distribution, also opens up the possibility to mimic organs like
liver and kidney with their interpenetrating tubular networks in vitro. This method has
potential to plot different types of cells and growth factors with alginate based pastes to
form a tissue implant with pre-vascularisation, which provides a platform for promoting
vascularisation in vitro. Preliminary experiments in our group indicated the possibility of
plotting two types of materials into core/shell structures through core/shell needles. Figure
6.1B (provided by Ashwini Rahul Akkineni in our group) shows that low concentrated
alginate (4%, dyed with blue ink) could be plotted through a core needle and high
concentrated alginate (16.7%) through the shell needle with adapted dosing pressure. The
resulting core/shell structures can be observed clearly.
On the other hand, the materials for preparing hollow fibers and hollow fiber scaffolds for
tissue engineering are not only limited to alginate/PVA pastes. Other materials including
gelatin (Figure 6.2A), collagen and other synthetic polymers like PLGA, PCL and their
composites, and even inorganic materials such as CPC (Figure 6.2B) are all able to
produce hollow fiber and hollow fiber scaffolds by this simple method.
Figure 6.2: Microscope images of plotted gelatin/alginate (mass ratio 2/5) (A) and CPC (B)
hollow fibers in wet state. The used core/shell needles size was 840/250 µm.
In addition, the surface morphology of the scaffolds is tailorable. Mineralized alginate
scaffolds with a layer of apatite deposited on the surface (inner and outer surfaces of
hollow strands) were fabricated. SEM pictures showed the open and connected hollow
channels and the improved roughness of the surface (Figure 6.3). Furthermore, bipartite
scaffolds of CPC/alginate (and/or gelatin) for repairing osteochondral defects containing
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hollow fibres also can be realized by combining plotting of cells and growth factors. A
corresponding CAD model is shown in Figure 6.4.
Figure 6.3: SEM images of alginate hollow fiber scaffolds mineralized with apatite on the
surface in the cross-section view (A, B and C) and high magnification on the surface
(D).
Figure 6.4: The CAD model of bi-layered scaffold for repairing of osteochondral defect
containing hollow fibers for vascularization
Polymer (alginate, gelatin)
Ceramics (CPC, bioglass)
Polymer hollow fiber
6. Summary and outlook
123
In conclusion, 3D plotting as it was investigated in this doctoral thesis project, opens up a
variety of options due to the reusability of suitable (bio-) materials and the mild
preparation conditions.
By including more and other materials, and living cells in the 3D plotting process, a
variety of more or less complex 3D scaffolds, tissue engineering constructs or even organ
models will be available in future.
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Appendices
Appendix A. Calcium phosphate cement (CPC) scaffolds
Figure A1: Microscopical images of plotted CPC strands, derived by varying the plotting
velocity and dosing pressure with different needle sizes (stainless steel needles);
needle size (ID) (µm)/pressure (bar) were: 610/4.8 (A), 410/5.4 (B), 410/6.6 (C) and
200/7.7 (D). Scale bar = 500 µm.
Figure A2: The relationship between plotting speed (velocity) and the width of plotted CPC strand
under different dosing pressure with cone-like plastic needle. Inner diameter of the
needle was 610 µm (A) and 840 µm (B), respectively.
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Appendix B. Alginate/PVA scaffolds
Figure B1: The relationship between plotting speed and the width of alginate/PVA (3/1) strand
under different dosing pressures (ID of the cone-like needle was 610 µm).
Figure B2: Microscopical images of plotted alginate/PVA (3/1) (A) and pure alginate (1/0) (B)
scaffold from the top view. (ID of needles was 610µm).
Figure B3: Photograph of alginate/PVA scaffolds after incubation in SBF (37°Ϲ) for 42 days 
(before drying). It can be seen that alginate/PVA (with different mass ratio) scaffolds
still kept their regular structures after incubation in SBF over 42 days.
1/0 1/1 2/1 3/1
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Appendix C. CPC/alginate biphasic scaffolds
Figure C1: Microscopical images of biphasic CPC/alginate scaffold (A, B and C) and mixed
CaP/alginate scaffolds (D, E and F) in top (A and D) and side (B and E) and bottom
view (C and F) in wet state.
Appendix D. Alginate/apatite core/shell scaffodls
Figure D1: Photographs of plotting alginate/Na2HPO4 scaffold in air (A), alginate/apatite
formation during incubation in CaCl2 solution (pH=9.5) (B-a) and pure alginate
scaffold in CaCl2 solution (B-b). Solution used for incubation of alginate/Na2HPO4
scaffold was turbid and white precipitates appeared compared to pure alginate
incubated solution, which was remained clear.
A B
a b
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Figure D2: Microscopical images of alginate/apatite core/shell (A) and mixed alginate/HAP (B)
scaffold in cross-section. The alginate/HAP core/shell structure and the open and
interconnected pores were observed clearly. Scale bar = 250 µm.
Figure D3: SEM micrographs of hBMSC on alginate/apatite core/shell scaffold on day 1 in
different magnification (white arrows indicated the nano apatite layer).
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Appendix E. MBG and MBG/alginate scaffolds
Figure E1: Mechanical measurement curves of alginate/MBG scaffolds with XY pattern on day 0
(A) and day 28 (B) after incubation in SBF.
Figure E2: SEM images of cells on 10% MBG/alginate scaffolds on day 1 (A, B) and apatite
deposition on 50% MBG/alginate scaffolds after incubation in cell culture medium
with osteogenic supplements for 7 days (C).
A B
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Appendix F. Gelatin/HAP/alginate scaffolds
Figure F1: Photographs of plotted gelatin/HAP/alginate scaffolds after crosslinking and drying.
Mass ratio from left to right: 58/0/42; 39/31/30; 50/20/30 (A). MTT stain picture of
gelatin/HAP/alginate (39/31/30) scaffold after seeding with hBMSC and incubaion
for 1day. Scaffold with seeded cells (left) and without seeding cells as blank control
(right) (B).
Figure F2: Microscopical pictures of MTT stained hBMSC on Gelatin/HAP/alginate scaffolds for
1 day; 39/31/30 mismatch structures (A, B) and regular structure (C); 50/20/30
mismatch (D) and 54/0/46 mismatch (E) and blank (without seeding cells) as control
(F). Scale bar = 200 µm.
A C
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Figure F3: Microscopical pictures of MTT stained hBMSC on gelatin/HAP/alginate (39/31/30)
(A, C) and gelatin/alginate (54/46) (B, D) scaffolds on 21 days; top view (A, B) and
cross-section view (C, D).
Figure F4: SEM images of hBMSC after culturing on gelatin/alginate (54/46) scaffold for 1 day (A)
and 21 days (B).
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Appendix F. 3D hollow fibers and hollow fiber scaffolds
Figure G1: Hollow fibers prepared from 2 wt % alginate sols and constructed multi-needles (A
and B), photograph (C) and microscopical images of the end (D) and center of the
hollow fibers (E). Black arrow (C) indicate the open hollow on the end of the fibers.
Microscopical image of non-hollow fiber as control was presented in (F). The hollow
alginate fibers prepared from low concentrated (2 wt %) alginate have shin fiber wall
but also weak mechanical properties and were unstable to be hand-treated. They have
to be kept in CaCl2 solution to maintain the hollow channels open.
Figure G2: Photographs of long alginate/PVA hollow fibers prepared with core/shell needles of
610/150 (A) and 840/200 µm (B). The prepared fibers were stable enough to support
their hollow channel structures in air.
A B
E FD
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Figure G3: Photographs of plotted hollow (A, B and C) and non-hollow (D, E and F) fiber
scaffolds on overview (A, D), at the end (B, E) and middle (C, F) of the strands.
A B C
D E F
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